{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:24:24Z","timestamp":1791915864230,"version":"4.3.4"},"reference-count":350,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Dis Primers"],"DOI":"10.1038\/s41572-023-00417-6","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T04:03:00Z","timestamp":1676520180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":832,"title":["Pre-eclampsia"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8698-1927","authenticated-orcid":false,"given":"Evdokia","family":"Dimitriadis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2263-3592","authenticated-orcid":false,"given":"Daniel L.","family":"Rolnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Estrada-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5057-4120","authenticated-orcid":false,"given":"Kaori","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana P. V.","family":"Francisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Hyett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabricio","family":"da Silva Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kypros","family":"Nicolaides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2440-6665","authenticated-orcid":false,"given":"Ellen","family":"Menkhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"key":"417_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijgo.12802","volume":"145","author":"L Poon","year":"2019","unstructured":"Poon, L. et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia. Int. J. Gynaecol. Obstet. 145, 1 (2019).","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"417_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","volume":"27","author":"LA Magee","year":"2022","unstructured":"Magee, L. A. et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 27, 148\u2013169 (2022). This paper outlines best-practice guidelines for diagnosis and management of pre-eclampsia.","journal-title":"Pregnancy Hypertens."},{"key":"417_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.16683","author":"T Pittara","year":"2021","unstructured":"Pittara, T., Vyrides, A., Lamnisos, D. & Giannakou, K. Pre-eclampsia and long-term health outcomes for mother and infant: an umbrella review. BJOG https:\/\/doi.org\/10.1111\/1471-0528.16683 (2021).","journal-title":"BJOG"},{"key":"417_CR4","doi-asserted-by":"publisher","first-page":"m1007","DOI":"10.1136\/bmj.m1007","volume":"369","author":"L Kvalvik","year":"2020","unstructured":"Kvalvik, L., Wilcox, A. J., Skj\u00e6rven, R., \u00d8stbye, T. & Harmon, Q. E. Term complications and subsequent risk of preterm birth. BMJ 369, m1007 (2020).","journal-title":"BMJ"},{"key":"417_CR5","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-3093","volume":"129","author":"E Davis","year":"2012","unstructured":"Davis, E. et al. Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics 129, e1552 (2012).","journal-title":"Pediatrics"},{"key":"417_CR6","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/uog.17455","volume":"49","author":"N O\u2019Gorman","year":"2017","unstructured":"O\u2019Gorman, N. et al. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks\u2019 gestation. Ultrasound Obstet. Gynecol. 49, 756 (2017).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"417_CR7","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJMoa1704559","volume":"377","author":"D Rolnik","year":"2017","unstructured":"Rolnik, D. et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N. Engl. J. Med. 377, 613 (2017). A convincing large trial of aspirin to prevent pre-eclampsia in women at high risk for preterm pre-eclampsia that sparked many follow-up trials and resulted in the worldwide clinical use of aspirin to prevent preterm pre-eclampsia.","journal-title":"N. Engl. J. Med."},{"key":"417_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.120.14781","author":"JM Roberts","year":"2021","unstructured":"Roberts, J. M., Rich-Edwards, J. W., McElrath, T. F. & Garmire, L. Subtypes of preeclampsia: recognition and determining clinical usefulness. Hypertension https:\/\/doi.org\/10.1161\/hypertensionaha.120.14781 (2021).","journal-title":"Hypertension"},{"key":"417_CR9","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/ppe.12759","volume":"35","author":"JF Simard","year":"2021","unstructured":"Simard, J. F. et al. Evidence of under-reporting of early-onset preeclampsia using register data. Paediatr. Perinat. Epidemiol. 35, 596\u2013600 (2021).","journal-title":"Paediatr. Perinat. Epidemiol."},{"key":"417_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20174246","author":"T Tomimatsu","year":"2019","unstructured":"Tomimatsu, T. et al. Preeclampsia: maternal systemic vascular disorder caused by generalized endothelial dysfunction due to placental antiangiogenic factors. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20174246 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"417_CR11","first-page":"403","volume":"11","author":"LM Amaral","year":"2015","unstructured":"Amaral, L. M., Cunningham, M. W. Jr, Cornelius, D. C. & LaMarca, B. Preeclampsia: long-term consequences for vascular health. Vasc. Health Risk Manag. 11, 403\u2013415 (2015).","journal-title":"Vasc. Health Risk Manag."},{"key":"417_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.preghy.2019.09.004","volume":"18","author":"T Paul","year":"2019","unstructured":"Paul, T. et al. Prediction of adverse maternal outcomes in preeclampsia at term. Pregnancy Hypertens. 18, 75 (2019).","journal-title":"Pregnancy Hypertens."},{"key":"417_CR13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","volume":"13","author":"MA Brown","year":"2018","unstructured":"Brown, M. A. et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 13, 291\u2013310 (2018).","journal-title":"Pregnancy Hypertens."},{"key":"417_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","volume":"170","author":"E Abalos","year":"2013","unstructured":"Abalos, E., Cuesta, C., Grosso, A. L., Chou, D. & Say, L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur. J. Obstet. Gynecol. Reprod. Biol. 170, 1\u20137 (2013).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"417_CR15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/uog.19039","volume":"51","author":"MY Tan","year":"2018","unstructured":"Tan, M. Y. et al. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE. Ultrasound Obstet. Gynecol. 51, 743\u2013750 (2018).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"417_CR16","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/uog.19019","volume":"51","author":"LC Poon","year":"2018","unstructured":"Poon, L. C. et al. ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm. Ultrasound Obstet. Gynecol. 51, 738\u2013742 (2018).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"417_CR17","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/ajo.12126","volume":"53","author":"FJ Park","year":"2013","unstructured":"Park, F. J. et al. Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy. Aust. NZ J. Obstet. Gynaecol. 53, 532\u2013539 (2013).","journal-title":"Aust. NZ J. Obstet. Gynaecol."},{"key":"417_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.preghy.2022.02.006","volume":"28","author":"D Wertaschnigg","year":"2022","unstructured":"Wertaschnigg, D. et al. Hypertensive disorders in pregnancy\u2013trends over eight years: a population-based cohort study. Pregnancy Hypertens. 28, 60\u201365 (2022).","journal-title":"Pregnancy Hypertens."},{"key":"417_CR19","doi-asserted-by":"publisher","first-page":"672446","DOI":"10.3389\/frph.2021.672446","volume":"3","author":"EM Lokken","year":"2021","unstructured":"Lokken, E. M. et al. Pooled prevalence of adverse pregnancy and neonatal outcomes in Malawi, South Africa, Uganda, and Zimbabwe: results from a systematic review and meta-analyses to inform trials of novel HIV prevention interventions during pregnancy. Front. Reprod. Health 3, 672446 (2021).","journal-title":"Front. Reprod. Health"},{"key":"417_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/1471-0528.12629","volume":"121","author":"E Abalos","year":"2014","unstructured":"Abalos, E. et al. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization multicountry survey on maternal and newborn health. BJOG 121, 14\u201324 (2014).","journal-title":"BJOG"},{"key":"417_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160562","volume":"11","author":"S Hodgins","year":"2016","unstructured":"Hodgins, S. et al. A new look at care in pregnancy: simple, effective interventions for neglected populations. PLoS ONE\u00a011, e0160562 (2016).","journal-title":"PLoS ONE"},{"key":"417_CR22","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","volume":"367","author":"KS Khan","year":"2006","unstructured":"Khan, K. S., Wojdyla, D., Say, L., G\u00fclmezoglu, A. M. & Van Look, P. F. WHO analysis of causes of maternal death: a systematic review. Lancet 367, 1066\u20131074 (2006).","journal-title":"Lancet"},{"key":"417_CR23","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","volume":"2","author":"L Say","year":"2014","unstructured":"Say, L. et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob. Health 2, e323\u2013e333 (2014).","journal-title":"Lancet Glob. Health"},{"key":"417_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.17320","author":"T Elawad","year":"2022","unstructured":"Elawad, T. et al. Risk factors for pre-eclampsia in clinical practice guidelines: comparison with the evidence. BJOG https:\/\/doi.org\/10.1111\/1471-0528.17320 (2022).","journal-title":"BJOG"},{"key":"417_CR25","first-page":"e1","volume":"133","author":"No authors listed.","year":"2019","unstructured":"[No authors listed.] ACOG practice bulletin No 202: gestational hypertension and preeclampsia. Obstet. Gynecol. 133, e1\u2013e25 (2019).","journal-title":"Obstet. Gynecol."},{"key":"417_CR26","doi-asserted-by":"publisher","first-page":"l5119","DOI":"10.1136\/bmj.l5119","volume":"366","author":"K Webster","year":"2019","unstructured":"Webster, K., Fishburn, S., Maresh, M., Findlay, S. C. & Chappell, L. C. Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance. BMJ 366, l5119 (2019).","journal-title":"BMJ"},{"key":"417_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2019-001759","volume":"4","author":"T Heestermans","year":"2019","unstructured":"Heestermans, T. et al. Prognostic models for adverse pregnancy outcomes in low-income and middle-income countries: a systematic review. BMJ Glob. Health 4, e001759 (2019).","journal-title":"BMJ Glob. Health"},{"key":"417_CR28","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/j.1471-0528.1986.tb08006.x","volume":"93","author":"LC Chesley","year":"1986","unstructured":"Chesley, L. C. & Cooper, D. W. Genetics of hypertension in pregnancy: possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women. BJOG 93, 898\u2013908 (1986).","journal-title":"BJOG"},{"key":"417_CR29","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/j.1471-0528.1990.tb02569.x","volume":"97","author":"R Arngrimsson","year":"1990","unstructured":"Arngrimsson, R. et al. Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Br. J. Obstet. Gynaecol. 97, 762\u2013769 (1990).","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"417_CR30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/bmj.38380.674340.E0","volume":"330","author":"K Duckitt","year":"2005","unstructured":"Duckitt, K. & Harrington, D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330, 565 (2005).","journal-title":"BMJ"},{"key":"417_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0020-7292(97)00241-5","volume":"60","author":"RB Cincotta","year":"1998","unstructured":"Cincotta, R. B. & Brennecke, S. P. Family history of pre-eclampsia as a predictor for pre-eclampsia in primigravidas. Int. J. Gynaecol. Obstet. 60, 23\u201327 (1998).","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"417_CR32","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1093\/aje\/kwt189","volume":"178","author":"HA Boyd","year":"2013","unstructured":"Boyd, H. A., Tahir, H., Wohlfahrt, J. & Melbye, M. Associations of personal and family preeclampsia history with the risk of early-, intermediate- and late-onset preeclampsia. Am. J. Epidemiol. 178, 1611\u20131619 (2013).","journal-title":"Am. J. Epidemiol."},{"key":"417_CR33","doi-asserted-by":"publisher","first-page":"5976","DOI":"10.1038\/s41467-020-19733-6","volume":"11","author":"V Steinthorsdottir","year":"2020","unstructured":"Steinthorsdottir, V. et al. Genetic predisposition to hypertension is associated with preeclampsia in European and Central Asian women. Nat. Commun. 11, 5976\u20135976 (2020).","journal-title":"Nat. Commun."},{"key":"417_CR34","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/aje\/kwu151","volume":"180","author":"FM Fong","year":"2014","unstructured":"Fong, F. M. et al. Maternal genotype and severe preeclampsia: a HuGE review. Am. J. Epidemiol. 180, 335\u2013345 (2014).","journal-title":"Am. J. Epidemiol."},{"key":"417_CR35","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1034\/j.1600-0412.2002.811201.x","volume":"81","author":"C Benedetto","year":"2002","unstructured":"Benedetto, C. et al. Factor V Leiden and factor II G20210A in preeclampsia and HELLP syndrome. Acta Obstet. Gynecol. Scand. 81, 1095\u20131100 (2002).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"417_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100789","volume":"9","author":"X Wang","year":"2014","unstructured":"Wang, X., Bai, T., Liu, S., Pan, H. & Wang, B. Association between thrombophilia gene polymorphisms and preeclampsia: a meta-analysis. PLoS ONE 9, e100789 (2014).","journal-title":"PLoS ONE"},{"key":"417_CR37","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ejogrb.2020.08.005","volume":"253","author":"NA Ahmed","year":"2020","unstructured":"Ahmed, N. A., Hamdan, H. Z., Kamis, A. H. & Adam, I. The association of the prothrombin G20210A single-nucleotide polymorphism and the risk of preeclampsia: systematic review and meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 253, 162\u2013169 (2020).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"417_CR38","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2021.1918092","author":"F Nasri","year":"2021","unstructured":"Nasri, F. et al. Are genetic variations in IL-1\u03b2 and IL-6 cytokines associated with the risk of pre-eclampsia? Evidence from a systematic review and meta-analysis. J. Matern. Fetal Neonatal Med. https:\/\/doi.org\/10.1080\/14767058.2021.1918092 (2021).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"417_CR39","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1084\/jem.20041214","volume":"200","author":"SE Hiby","year":"2004","unstructured":"Hiby, S. E. et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 200, 957\u2013965 (2004).","journal-title":"J. Exp. Med."},{"key":"417_CR40","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1111\/jog.14751","volume":"47","author":"J Liu","year":"2021","unstructured":"Liu, J., Song, G., Zhao, G. & Meng, T. Gene polymorphism associated with TGF-\u03b21 and susceptibility to preeclampsia: a meta-analysis and trial sequential analysis. J. Obstet. Gynaecol. Res. 47, 2031\u20132041 (2021).","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"417_CR41","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1080\/14767058.2017.1332037","volume":"31","author":"SK Dotters-Katz","year":"2018","unstructured":"Dotters-Katz, S. K. et al. Trisomy 13 and the risk of gestational hypertensive disorders: a population-based study. J. Matern. Fetal Neonatal Med. 31, 1951\u20131955 (2018).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"417_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1414838","volume":"374","author":"H Zeisler","year":"2016","unstructured":"Zeisler, H. et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N. Engl. J. Med. 374, 13\u201322 (2016).","journal-title":"N. Engl. J. Med."},{"key":"417_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198166","volume":"13","author":"MF Feitosa","year":"2018","unstructured":"Feitosa, M. F. et al. Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries. PLoS ONE 13, e0198166 (2018).","journal-title":"PLoS ONE"},{"key":"417_CR44","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ajhg.2018.01.015","volume":"102","author":"YJ Sung","year":"2018","unstructured":"Sung, Y. J. et al. A large-scale multi-ancestry genome-wide study accounting for smoking behavior identifies multiple significant loci for blood pressure. Am. J. Hum. Genet. 102, 375\u2013400 (2018).","journal-title":"Am. J. Hum. Genet."},{"key":"417_CR45","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1126\/science.1141634","volume":"316","author":"TM Frayling","year":"2007","unstructured":"Frayling, T. M. et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316, 889\u2013894 (2007).","journal-title":"Science"},{"key":"417_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1365-3016.2011.01222.x","volume":"26","author":"J Gong","year":"2012","unstructured":"Gong, J., Savitz, D. A., Stein, C. R. & Engel, S. M. Maternal ethnicity and pre-eclampsia in New York City, 1995-2003. Paediatr. Perinat. Epidemiol. 26, 45\u201352 (2012).","journal-title":"Paediatr. Perinat. Epidemiol."},{"key":"417_CR47","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1007\/s10995-012-1162-0","volume":"17","author":"S Zhang","year":"2013","unstructured":"Zhang, S. et al. Racial disparities in economic and clinical outcomes of pregnancy among Medicaid recipients. Matern. Child Health J. 17, 1518\u20131525 (2013).","journal-title":"Matern. Child Health J."},{"key":"417_CR48","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1479-828X.2012.01475.x","volume":"52","author":"NH Anderson","year":"2012","unstructured":"Anderson, N. H., Sadler, L. C., Stewart, A. W., Fyfe, E. M. & McCowan, L. M. Ethnicity, body mass index and risk of pre-eclampsia in a multiethnic New Zealand population. Aust. NZ J. Obstet. Gynaecol. 52, 552\u2013558 (2012).","journal-title":"Aust. NZ J. Obstet. Gynaecol."},{"key":"417_CR49","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1136\/pgmj.2007.066381","volume":"84","author":"R Ramaraj","year":"2008","unstructured":"Ramaraj, R. & Chellappa, P. Cardiovascular risk in South Asians. Postgrad. Med. J. 84, 518\u2013523 (2008).","journal-title":"Postgrad. Med. J."},{"key":"417_CR50","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/sj.jhh.1000516","volume":"11","author":"FP Cappuccio","year":"1997","unstructured":"Cappuccio, F. P. Ethnicity and cardiovascular risk: variations in people of African ancestry and South Asian origin. J. Hum. Hypertens. 11, 571\u2013576 (1997).","journal-title":"J. Hum. Hypertens."},{"key":"417_CR51","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1136\/hrt.78.6.555","volume":"78","author":"FP Cappuccio","year":"1997","unstructured":"Cappuccio, F. P., Cook, D. G., Atkinson, R. W. & Strazzullo, P. Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London. Heart 78, 555\u2013563 (1997).","journal-title":"Heart"},{"key":"417_CR52","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.17240","author":"A Arechvo","year":"2022","unstructured":"Arechvo, A. et al. Maternal race and preeclampsia: cohort study and systematic review with meta-analysis. BJOG https:\/\/doi.org\/10.1111\/1471-0528.17240 (2022).","journal-title":"BJOG"},{"key":"417_CR53","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1111\/1471-0528.17109","volume":"129","author":"B Liu","year":"2022","unstructured":"Liu, B. et al. Reducing health inequality in Black, Asian and other minority ethnic pregnant women: impact of first trimester combined screening for placental dysfunction on perinatal mortality. BJOG 129, 1750\u20131756 (2022).","journal-title":"BJOG"},{"key":"417_CR54","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/0029-7844(96)00045-2","volume":"87","author":"A Bianco","year":"1996","unstructured":"Bianco, A. et al. Pregnancy outcome at age 40 and older. Obstet. Gynecol. 87, 917\u2013922 (1996).","journal-title":"Obstet. Gynecol."},{"key":"417_CR55","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/jhh.2009.45","volume":"24","author":"LC Poon","year":"2010","unstructured":"Poon, L. C., Kametas, N. A., Chelemen, T., Leal, A. & Nicolaides, K. H. Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. J. Hum. Hypertens. 24, 104\u2013110 (2010).","journal-title":"J. Hum. Hypertens."},{"key":"417_CR56","first-page":"491","volume":"41","author":"R Mittendorf","year":"1996","unstructured":"Mittendorf, R., Lain, K. Y., Williams, M. A. & Walker, C. K. Preeclampsia. A nested, case-control study of risk factors and their interactions. J. Reprod. Med. 41, 491\u2013496 (1996).","journal-title":"J. Reprod. Med."},{"key":"417_CR57","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2020.1786516","author":"P-Y Robillard","year":"2020","unstructured":"Robillard, P.-Y. et al. The blurring boundaries between placental and maternal preeclampsia: a critical appraisal of 1800 consecutive preeclamptic cases. J. Matern. Fetal Neonatal Med. https:\/\/doi.org\/10.1080\/14767058.2020.1786516 (2020).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"417_CR58","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1471-0528.2000.tb11582.x","volume":"107","author":"A Conde-Agudelo","year":"2000","unstructured":"Conde-Agudelo, A. & Beliz\u00e1n, J. M. Risk factors for pre-eclampsia in a large cohort of Latin American and Caribbean women. BJOG 107, 75\u201383 (2000).","journal-title":"BJOG"},{"key":"417_CR59","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa2201295","volume":"386","author":"AT Tita","year":"2022","unstructured":"Tita, A. T. et al. Treatment for mild chronic hypertension during pregnancy. N. Engl. J. Med. 386, 1781\u20131792 (2022).","journal-title":"N. Engl. J. Med."},{"key":"417_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223888","volume":"14","author":"PY Robillard","year":"2019","unstructured":"Robillard, P. Y. et al. Increased BMI has a linear association with late-onset preeclampsia: a population-based study. PLoS ONE 14, e0223888 (2019).","journal-title":"PLoS ONE"},{"key":"417_CR61","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1159\/000328083","volume":"30","author":"A Syngelaki","year":"2011","unstructured":"Syngelaki, A., Bredaki, F. E., Vaikousi, E., Maiz, N. & Nicolaides, K. H. Body mass index at 11-13 weeks\u2019 gestation and pregnancy complications. Fetal Diagn. Ther. 30, 250\u2013265 (2011).","journal-title":"Fetal Diagn. Ther."},{"key":"417_CR62","doi-asserted-by":"publisher","first-page":"270","DOI":"10.5468\/ogs.2020.63.3.270","volume":"63","author":"P Wadhwani","year":"2020","unstructured":"Wadhwani, P., Saha, P. K., Kalra, J. K., Gainder, S. & Sundaram, V. A study to compare maternal and perinatal outcome in early vs. late onset preeclampsia. Obstet. Gynecol. Sci. 63, 270\u2013277 (2020).","journal-title":"Obstet. Gynecol. Sci."},{"key":"417_CR63","doi-asserted-by":"publisher","first-page":"651.e1","DOI":"10.1016\/j.ajog.2015.11.024","volume":"214","author":"JK Durst","year":"2016","unstructured":"Durst, J. K., Tuuli, M. G., Stout, M. J., Macones, G. A. & Cahill, A. G. Degree of obesity at delivery and risk of preeclampsia with severe features. Am. J. Obstet. Gynecol. 214, 651.e1\u2013651.e5 (2016).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR64","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/AOG.0000000000003573","volume":"135","author":"JA Mart\u00ednez-Hortelano","year":"2020","unstructured":"Mart\u00ednez-Hortelano, J. A. et al. Interpregnancy weight change and hypertension during pregnancy: a systematic review and meta-analysis. Obstet. Gynecol. 135, 68\u201379 (2020).","journal-title":"Obstet. Gynecol."},{"key":"417_CR65","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1136\/bjsports-2018-099355","volume":"52","author":"MH Davenport","year":"2018","unstructured":"Davenport, M. H. et al. Prenatal exercise for the prevention of gestational diabetes mellitus and hypertensive disorders of pregnancy: a systematic review and meta-analysis. Br. J. Sports Med. 52, 1367 (2018).","journal-title":"Br. J. Sports Med."},{"key":"417_CR66","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/0002-9378(90)91184-E","volume":"163","author":"PR Garner","year":"1990","unstructured":"Garner, P. R., D\u2019Alton, M. E., Dudley, D. K., Huard, P. & Hardie, M. Preeclampsia in diabetic pregnancies. Am. J. Obstet. Gynecol. 163, 505\u2013508 (1990).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR67","doi-asserted-by":"publisher","first-page":"831297","DOI":"10.3389\/fcvm.2022.831297","volume":"9","author":"Y Yang","year":"2022","unstructured":"Yang, Y. & Wu, N. Gestational diabetes mellitus and preeclampsia: correlation and influencing factors. Front. Cardiovasc. Med. 9, 831297 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"417_CR68","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ajog.2021.10.037","volume":"226","author":"S Al Khalaf","year":"2022","unstructured":"Al Khalaf, S. et al. Chronic kidney disease and adverse pregnancy outcomes: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. 226, 656\u2013670.e32 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR69","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S2213-8587(22)00007-9","volume":"10","author":"FJK Toloza","year":"2022","unstructured":"Toloza, F. J. K. et al. Association between maternal thyroid function and risk of gestational hypertension and pre-eclampsia: a systematic review and individual-participant data meta-analysis. Lancet Diabetes Endocrinol. 10, 243\u2013252 (2022).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"417_CR70","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/OGX.0000000000000547","volume":"73","author":"DR Shinohara","year":"2018","unstructured":"Shinohara, D. R. et al. Pregnancy complications associated with maternal hypothyroidism: a systematic review. Obstet. Gynecol. Surv. 73, 219\u2013230 (2018).","journal-title":"Obstet. Gynecol. Surv."},{"key":"417_CR71","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/humupd\/dms007","volume":"18","author":"R Vissenberg","year":"2012","unstructured":"Vissenberg, R. et al. Treatment of thyroid disorders before conception and in early pregnancy: a systematic review. Hum. Reprod. Update 18, 360\u2013373 (2012).","journal-title":"Hum. Reprod. Update"},{"key":"417_CR72","doi-asserted-by":"publisher","first-page":"800257","DOI":"10.3389\/fendo.2022.800257","volume":"13","author":"JM Alves Junior","year":"2022","unstructured":"Alves Junior, J. M., Bernardo, W. M., Ward, L. S. & Villagelin, D. Effect of hyperthyroidism control during pregnancy on maternal and fetal outcome: a systematic review and meta-analysis. Front. Endocrinol. 13, 800257 (2022).","journal-title":"Front. Endocrinol."},{"key":"417_CR73","doi-asserted-by":"publisher","first-page":"964084","DOI":"10.3389\/fendo.2022.964084","volume":"13","author":"X-F Jiao","year":"2022","unstructured":"Jiao, X.-F. et al. The impact of levothyroxine therapy on the pregnancy, neonatal and childhood outcomes of subclinical hypothyroidism during pregnancy: an updated systematic review, meta-analysis and trial sequential analysis. Front. Endocrinol. 13, 964084 (2022).","journal-title":"Front. Endocrinol."},{"key":"417_CR74","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1067\/mob.2000.103890","volume":"182","author":"DM Stamilio","year":"2000","unstructured":"Stamilio, D. M., Sehdev, H. M., Morgan, M. A., Propert, K. & Macones, G. A. Can antenatal clinical and biochemical markers predict the development of severe preeclampsia. Am. J. Obstet. Gynecol. 182, 589\u2013594 (2000).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR75","doi-asserted-by":"publisher","first-page":"127.e1","DOI":"10.1016\/j.ajog.2008.03.012","volume":"199","author":"MEB Clowse","year":"2008","unstructured":"Clowse, M. E. B., Jamison, M., Myers, E. & James, A. H. A national study of the complications of lupus in pregnancy. Am. J. Obstet. Gynecol. 199, 127.e1\u2013127.e6 (2008).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR76","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.thromres.2011.02.006","volume":"128","author":"K Abou-Nassar","year":"2011","unstructured":"Abou-Nassar, K., Carrier, M., Ramsay, T. & Rodger, M. A. The association between antiphospholipid antibodies and placenta mediated complications: a systematic review and meta-analysis. Thromb. Res. 128, 77\u201385 (2011).","journal-title":"Thromb. Res."},{"key":"417_CR77","doi-asserted-by":"publisher","first-page":"885","DOI":"10.2147\/TCRM.S160760","volume":"14","author":"J Wu","year":"2018","unstructured":"Wu, J., Ma, J., Zhang, W.-H. & Di, W. Management and outcomes of pregnancy with or without lupus nephritis: a systematic review and meta-analysis. Ther. Clin. Risk Manag. 14, 885\u2013901 (2018).","journal-title":"Ther. Clin. Risk Manag."},{"key":"417_CR78","doi-asserted-by":"publisher","first-page":"102901","DOI":"10.1016\/j.autrev.2021.102901","volume":"20","author":"IJ Walter","year":"2021","unstructured":"Walter, I. J. et al. Pregnancy outcome predictors in antiphospholipid syndrome: a systematic review and meta-analysis. Autoimmun. Rev. 20, 102901 (2021).","journal-title":"Autoimmun. Rev."},{"key":"417_CR79","first-page":"541","volume":"73","author":"DW Branch","year":"1989","unstructured":"Branch, D. W., Andres, R., Digre, K. B., Rote, N. S. & Scott, J. R. The association of antiphospholipid antibodies with severe preeclampsia. Obstet. Gynecol. 73, 541\u2013545 (1989).","journal-title":"Obstet. Gynecol."},{"key":"417_CR80","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/j.1471-0528.1993.tb15105.x","volume":"100","author":"NS Pattison","year":"1993","unstructured":"Pattison, N. S., Chamley, L. W., McKay, E. J., Liggins, G. C. & Butler, W. S. Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. Br. J. Obstet. Gynaecol. 100, 909\u2013913 (1993).","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"417_CR81","first-page":"29","volume":"97","author":"M Dreyfus","year":"2001","unstructured":"Dreyfus, M. et al. Antiphospholipid antibodies and preeclampsia: a case-control study. Obstet. Gynecol. 97, 29\u201334 (2001).","journal-title":"Obstet. Gynecol."},{"key":"417_CR82","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3109\/00016349209007966","volume":"71","author":"KE Sletnes","year":"1992","unstructured":"Sletnes, K. E., Wisl\u00f8ff, F., Moe, N. & Dale, P. O. Antiphospholipid antibodies in pre-eclamptic women: relation to growth retardation and neonatal outcome. Acta Obstet. Gynecol. Scand. 71, 112\u2013117 (1992).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"417_CR83","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1136\/gutjnl-2019-319101","volume":"69","author":"X Chen","year":"2020","unstructured":"Chen, X. et al. Gut dysbiosis induces the development of pre-eclampsia through bacterial translocation. Gut 69, 513 (2020).","journal-title":"Gut"},{"key":"417_CR84","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3389\/fcimb.2019.00224","volume":"9","author":"L-J Lv","year":"2019","unstructured":"Lv, L.-J. et al. Early-onset preeclampsia is associated with gut microbial alterations in antepartum and postpartum women. Front. Cell. Infect. Microbiol. 9, 224 (2019).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"417_CR85","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.humimm.2021.01.004","volume":"82","author":"A-RY Collier","year":"2021","unstructured":"Collier, A.-R. Y., Smith, L. A. & Karumanchi, S. A. Review of the immune mechanisms of preeclampsia and the potential of immune modulating therapy. Hum. Immunol. 82, 362\u2013370 (2021).","journal-title":"Hum. Immunol."},{"key":"417_CR86","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0002-9378(98)70160-7","volume":"179","author":"GA Dekker","year":"1998","unstructured":"Dekker, G. A. & Sibai, B. M. Etiology and pathogenesis of preeclampsia: current concepts. Am. J. Obstet. Gynecol. 179, 1359\u20131375 (1998).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0165-0378(93)90032-D","volume":"24","author":"PY Robillard","year":"1993","unstructured":"Robillard, P. Y. et al. Paternity patterns and risk of preeclampsia in the last pregnancy in multiparae. J. Reprod. Immunol. 24, 1\u201312 (1993).","journal-title":"J. Reprod. Immunol."},{"key":"417_CR88","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa011379","volume":"346","author":"R Skjaerven","year":"2002","unstructured":"Skjaerven, R., Wilcox, A. J. & Lie, R. T. The interval between pregnancies and the risk of preeclampsia. N. Engl. J. Med. 346, 33\u201338 (2002).","journal-title":"N. Engl. J. Med."},{"key":"417_CR89","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/humrep\/deab267","volume":"37","author":"A Keukens","year":"2022","unstructured":"Keukens, A., van Wely, M., van der Meulen, C. & Mochtar, M. H. Pre-eclampsia in pregnancies resulting from oocyte donation, natural conception or IVF: a systematic review and meta-analysis. Hum. Reprod. 37, 586\u2013599 (2022).","journal-title":"Hum. Reprod."},{"key":"417_CR90","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ejogrb.2022.05.031","volume":"274","author":"EM Pohjonen","year":"2022","unstructured":"Pohjonen, E. M. et al. Obstetric and perinatal risks after the use of donor sperm: a systematic review and meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 274, 210\u2013228 (2022).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"417_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-020-01107-4","volume":"23","author":"K Narang","year":"2020","unstructured":"Narang, K. & Szymanski, L. M. Multiple gestations and hypertensive disorders of pregnancy: what do we know? Curr. Hypertens. Rep. 23, 1 (2020).","journal-title":"Curr. Hypertens. Rep."},{"key":"417_CR92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221202","volume":"14","author":"JH Jhee","year":"2019","unstructured":"Jhee, J. H. et al. Prediction model development of late-onset preeclampsia using machine learning-based methods. PLoS ONE 14, e0221202 (2019).","journal-title":"PLoS ONE"},{"key":"417_CR93","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1471-0528.1985.tb01064.x","volume":"92","author":"DM Campbell","year":"1985","unstructured":"Campbell, D. M., MacGillivray, I. & Carr-Hill, R. Pre-eclampsia in second pregnancy. Br. J. Obstet. Gynaecol. 92, 131\u2013140 (1985).","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"417_CR94","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0020-7292(00)00240-X","volume":"70","author":"CJ Lee","year":"2000","unstructured":"Lee, C. J. et al. Risk factors for pre-eclampsia in an Asian population. Int. J. Gynaecol. Obstet. 70, 327\u2013333 (2000).","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"417_CR95","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1067\/mob.2002.123608","volume":"187","author":"D Mostello","year":"2002","unstructured":"Mostello, D., Catlin, T. K., Roman, L., Holcomb, W. L. Jr & Leet, T. Preeclampsia in the parous woman: who is at risk? Am. J. Obstet. Gynecol. 187, 425\u2013429 (2002).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR96","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/aogs.13846","volume":"99","author":"PY Robillard","year":"2020","unstructured":"Robillard, P. Y. et al. Validation of the 34-week gestation as definition of late onset preeclampsia: testing different cutoffs from 30 to 37 weeks on a population-based cohort of 1700 preeclamptics. Acta Obstet. Gynecol. Scand. 99, 1181\u20131190 (2020).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"417_CR97","doi-asserted-by":"publisher","first-page":"624.e1","DOI":"10.1016\/j.ajog.2015.01.009","volume":"212","author":"MF van Oostwaard","year":"2015","unstructured":"van Oostwaard, M. F. et al. Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis. Am. J. Obstet. Gynecol. 212, 624.e1\u2013624.e17 (2015).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001243","volume":"9","author":"S Bhattacharya","year":"2012","unstructured":"Bhattacharya, S., McLernon, D. J., Lee, A. J. & Bhattacharya, S. Reproductive outcomes following ectopic pregnancy: register-based retrospective cohort study. PLoS Med. 9, e1001243 (2012).","journal-title":"PLoS Med."},{"key":"417_CR99","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/S0002-9378(97)70004-8","volume":"177","author":"BM Sibai","year":"1997","unstructured":"Sibai, B. M. et al. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am. J. Obstet. Gynecol. 177, 1003\u20131010 (1997).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR100","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/j.1447-0756.2012.02010.x","volume":"39","author":"A Aksornphusitaphong","year":"2013","unstructured":"Aksornphusitaphong, A. & Phupong, V. Risk factors of early and late onset pre-eclampsia. J. Obstet. Gynaecol. Res. 39, 627\u2013631 (2013).","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"417_CR101","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1093\/humrep\/dev090","volume":"30","author":"S Opdahl","year":"2015","unstructured":"Opdahl, S. et al. Risk of hypertensive disorders in pregnancies following assisted reproductive technology: a cohort study from the CoNARTaS group. Hum. Reprod. 30, 1724\u20131731 (2015).","journal-title":"Hum. Reprod."},{"key":"417_CR102","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1161\/HYPERTENSIONAHA.118.12046","volume":"73","author":"F von Versen-H\u00f6ynck","year":"2019","unstructured":"von Versen-H\u00f6ynck, F. et al. Absent or excessive corpus luteum number is associated with altered maternal vascular health in early pregnancy. Hypertension 73, 680\u2013690 (2019).","journal-title":"Hypertension"},{"key":"417_CR103","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1056\/NEJMoa1705334","volume":"378","author":"Y Shi","year":"2018","unstructured":"Shi, Y. et al. Transfer of fresh versus frozen embryos in ovulatory women. N. Engl. J. Med. 378, 126\u2013136 (2018).","journal-title":"N. Engl. J. Med."},{"key":"417_CR104","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1093\/humrep\/dez079","volume":"34","author":"K Saito","year":"2019","unstructured":"Saito, K. et al. Endometrial preparation methods for frozen-thawed embryo transfer are associated with altered risks of hypertensive disorders of pregnancy, placenta accreta, and gestational diabetes mellitus. Hum. Reprod. 34, 1567\u20131575 (2019).","journal-title":"Hum. Reprod."},{"key":"417_CR105","doi-asserted-by":"publisher","first-page":"S886","DOI":"10.1016\/j.ajog.2020.09.039","volume":"226","author":"T Garrido-G\u00f3mez","year":"2022","unstructured":"Garrido-G\u00f3mez, T., Castillo-Marco, N., Cordero, T. & Sim\u00f3n, C. Decidualization resistance in the origin of preeclampsia. Am. J. Obstet. Gynecol. 226, S886\u2013S894 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR106","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ajog.2021.07.009","volume":"226","author":"A Conde-Agudelo","year":"2022","unstructured":"Conde-Agudelo, A. & Romero, R. SARS-CoV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. 226, 68\u201389.e63 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR107","doi-asserted-by":"publisher","first-page":"6194","DOI":"10.3390\/jcm11206194","volume":"11","author":"S Yaghoobpoor","year":"2022","unstructured":"Yaghoobpoor, S. et al. Cardiovascular complications of COVID-19 among pregnant women and their fetuses: a systematic review. J. Clin. Med. 11, 6194 (2022).","journal-title":"J. Clin. Med."},{"key":"417_CR108","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ejogrb.2022.07.010","volume":"276","author":"E Mullins","year":"2022","unstructured":"Mullins, E. et al. Pregnancy and neonatal outcomes of COVID-19: the PAN-COVID study. Eur. J. Obstetr. Gynecol. Reprod. Biol. 276, 161\u2013167 (2022).","journal-title":"Eur. J. Obstetr. Gynecol. Reprod. Biol."},{"key":"417_CR109","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1749666","author":"D Getahun","year":"2022","unstructured":"Getahun, D. et al. Association between SARS-CoV-2 infection and adverse perinatal outcomes in a large health maintenance organization. Am. J. Perinatol. https:\/\/doi.org\/10.1055\/s-0042-1749666 (2022).","journal-title":"Am. J. Perinatol."},{"key":"417_CR110","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.jogc.2022.03.008","volume":"44","author":"JW Snelgrove","year":"2022","unstructured":"Snelgrove, J. W. et al. Preeclampsia and severe maternal morbidity during the COVID-19 pandemic: a population-based cohort study in Ontario, Canada. J. Obstet. Gynaecol. Can. 44, 777\u2013784 (2022).","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"417_CR111","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1097\/HJH.0000000000003213","volume":"40","author":"G Tossetta","year":"2022","unstructured":"Tossetta, G. et al. Preeclampsia and severe acute respiratory syndrome coronavirus 2 infection: a systematic review. J. Hypertens. 40, 1629\u20131638 (2022).","journal-title":"J. Hypertens."},{"key":"417_CR112","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.2741\/2286","volume":"12","author":"S Zamudio","year":"2007","unstructured":"Zamudio, S. High-altitude hypoxia and preeclampsia. Front. Biosci. 12, 2967\u20132977 (2007).","journal-title":"Front. Biosci."},{"key":"417_CR113","doi-asserted-by":"publisher","first-page":"F81","DOI":"10.1530\/REP-20-0349","volume":"161","author":"LG Moore","year":"2021","unstructured":"Moore, L. G. Hypoxia and reproductive health: reproductive challenges at high altitude: fertility, pregnancy and neonatal well-being. Reproduction 161, F81\u2013F90 (2021).","journal-title":"Reproduction"},{"key":"417_CR114","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.ajhg.2022.04.014","volume":"109","author":"MA Nieves-Col\u00f3n","year":"2022","unstructured":"Nieves-Col\u00f3n, M. A. et al. Clotting factor genes are associated with preeclampsia in high-altitude pregnant women in the Peruvian Andes. Am. J. Hum. Genet. 109, 1117\u20131139 (2022).","journal-title":"Am. J. Hum. Genet."},{"key":"417_CR115","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.3390\/ijerph17051744","volume":"17","author":"Y Mandakh","year":"2020","unstructured":"Mandakh, Y. et al. Maternal exposure to ambient air pollution and risk of preeclampsia: a population-based cohort study in Scania, Sweden. Int. J. Env. Res. Public Health 17, 1744 (2020).","journal-title":"Int. J. Env. Res. Public Health"},{"key":"417_CR116","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.placenta.2020.12.009","volume":"104","author":"E Bearblock","year":"2021","unstructured":"Bearblock, E., Aiken, C. E. & Burton, G. J. Air pollution and pre-eclampsia; associations and potential mechanisms. Placenta 104, 188\u2013194 (2021).","journal-title":"Placenta"},{"key":"417_CR117","doi-asserted-by":"publisher","first-page":"112934","DOI":"10.1016\/j.envres.2022.112934","volume":"210","author":"P Gogna","year":"2022","unstructured":"Gogna, P., Villeneuve, P. J., Borghese, M. M. & King, W. D. An exposure-response meta-analysis of ambient PM2.5 during pregnancy and preeclampsia. Environ. Res. 210, 112934 (2022).","journal-title":"Environ. Res."},{"key":"417_CR118","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0143-4004(80)80012-9","volume":"1","author":"R Pijnenborg","year":"1980","unstructured":"Pijnenborg, R., Dixon, G., Robertson, W. B. & Brosens, I. Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy. Placenta 1, 3\u201319 (1980).","journal-title":"Placenta"},{"key":"417_CR119","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/nrendo.2016.116","volume":"12","author":"J Evans","year":"2016","unstructured":"Evans, J. et al. Fertile ground: human endometrial programming and lessons in health and disease. Nat. Rev. Endocrinol. 12, 654\u2013667 (2016).","journal-title":"Nat. Rev. Endocrinol."},{"key":"417_CR120","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-5-6","volume":"5","author":"L Lunghi","year":"2007","unstructured":"Lunghi, L., Ferretti, M., Medici, S., Biondi, C. & Vesce, F. Control of human trophoblast function. Reprod. Biol. Endocrinol. 5, 6 (2007).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"417_CR121","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0143-4004(83)80043-5","volume":"4","author":"R Pijnenborg","year":"1983","unstructured":"Pijnenborg, R., Bland, J. M., Robertson, W. B. & Brosens, I. Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta 4, 397\u2013413 (1983).","journal-title":"Placenta"},{"key":"417_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05947-0","volume":"7","author":"E Menkhorst","year":"2017","unstructured":"Menkhorst, E. et al. Invasive trophoblast promote stromal fibroblast decidualization via Profilin 1 and ALOX5. Sci. Rep. 7, 8690 (2017).","journal-title":"Sci. Rep."},{"key":"417_CR123","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s00018-019-03374-0","volume":"77","author":"P Deryabin","year":"2020","unstructured":"Deryabin, P., Griukova, A., Nikolsky, N. & Borodkina, A. The link between endometrial stromal cell senescence and decidualization in female fertility: the art of balance. Cell. Mol. Life Sci. 77, 1357\u20131370 (2020).","journal-title":"Cell. Mol. Life Sci."},{"key":"417_CR124","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1387\/ijdb.082764gb","volume":"54","author":"GJ Burton","year":"2010","unstructured":"Burton, G. J., Jauniaux, E. & Charnock-Jones, D. S. The influence of the intrauterine environment on human placental development. Int. J. Dev. Biol. 54, 303\u2013312 (2010).","journal-title":"Int. J. Dev. Biol."},{"key":"417_CR125","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1093\/humrep\/der198","volume":"26","author":"GE Lash","year":"2011","unstructured":"Lash, G. E. et al. Interaction between uterine natural killer cells and extravillous trophoblast cells: effect on cytokine and angiogenic growth factor production. Hum. Reprod. 26, 2289\u20132295 (2011).","journal-title":"Hum. Reprod."},{"key":"417_CR126","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.placenta.2017.06.007","volume":"60","author":"GJ Burton","year":"2017","unstructured":"Burton, G. J. & Jauniaux, E. The cytotrophoblastic shell and complications of pregnancy. Placenta 60, 134\u2013139 (2017).","journal-title":"Placenta"},{"key":"417_CR127","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41574-020-0372-6","volume":"16","author":"JD Aplin","year":"2020","unstructured":"Aplin, J. D., Myers, J. E., Timms, K. & Westwood, M. Tracking placental development in health and disease. Nat. Rev. Endocrinol. 16, 479\u2013494 (2020).","journal-title":"Nat. Rev. Endocrinol."},{"key":"417_CR128","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev-physiol-020518-114435","volume":"81","author":"G Osol","year":"2019","unstructured":"Osol, G., Ko, N. L. & Mandal\u00e0, M. Plasticity of the maternal vasculature during pregnancy. Annu. Rev. Physiol. 81, 89\u2013111 (2019).","journal-title":"Annu. Rev. Physiol."},{"key":"417_CR129","doi-asserted-by":"publisher","first-page":"R155","DOI":"10.1530\/REP-18-0278","volume":"156","author":"S Kumar","year":"2018","unstructured":"Kumar, S., Gordon, G. H., Abbott, D. H. & Mishra, J. S. Androgens in maternal vascular and placental function: implications for preeclampsia pathogenesis. Reproduction 156, R155\u2013R167 (2018).","journal-title":"Reproduction"},{"key":"417_CR130","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3389\/fendo.2019.00563","volume":"10","author":"ER Lumbers","year":"2019","unstructured":"Lumbers, E. R., Delforce, S. J., Arthurs, A. L. & Pringle, K. G. Causes and consequences of the dysregulated maternal renin-angiotensin system in preeclampsia. Front. Endocrinol. 10, 563 (2019).","journal-title":"Front. Endocrinol."},{"key":"417_CR131","doi-asserted-by":"publisher","first-page":"H2011","DOI":"10.1152\/ajpheart.01005.2020","volume":"320","author":"MM Pereira","year":"2021","unstructured":"Pereira, M. M., Torrado, J., Sosa, C., Z\u00f3calo, Y. & Bia, D. Role of arterial impairment in preeclampsia: should the paradigm shift? Am. J. Physiol. Heart Circ. Physiol. 320, H2011\u2013H2030 (2021).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"417_CR132","unstructured":"Johnson, A. C. in Handbook of Clinical Neurology Vol. 171 (eds Steegers, E. A. P., Cipolla, M. J. & Miller, E. C.) 85\u201396 (Elsevier, 2020)."},{"key":"417_CR133","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.2215\/CJN.12081115","volume":"11","author":"E Phipps","year":"2016","unstructured":"Phipps, E., Prasanna, D., Brima, W. & Jim, B. Preeclampsia: updates in pathogenesis, definitions, and guidelines. Clin. J. Am. Soc. Nephrol. 11, 1102\u20131113 (2016).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"417_CR134","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.3389\/fimmu.2020.01864","volume":"11","author":"I Aneman","year":"2020","unstructured":"Aneman, I. et al. Mechanisms of key innate immune cells in early- and late-onset preeclampsia. Front. Immunol. 11, 1864 (2020).","journal-title":"Front. Immunol."},{"key":"417_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.09.047","author":"CWG Redman","year":"2020","unstructured":"Redman, C. W. G., Staff, A. C. & Roberts, J. M. Syncytiotrophoblast stress in preeclampsia: the convergence point for multiple pathways. Am. J. Obstet. Gynecol. https:\/\/doi.org\/10.1016\/j.ajog.2020.09.047 (2020). A comprehensive review of our understanding of the aetiology of pre-eclampsia that encompasses both preterm and term physiology.","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jri.2019.07.004","volume":"134-135","author":"A Staff","year":"2019","unstructured":"Staff, A. C. The two-stage placental model of preeclampsia: an update. J. Reprod. Immunol. 134\u2013135, 1\u201310 (2019).","journal-title":"J. Reprod. Immunol."},{"issue":"Suppl.","key":"417_CR137","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.placenta.2013.12.008","volume":"35","author":"CW Redman","year":"2014","unstructured":"Redman, C. W., Sargent, I. L. & Staff, A. C. IFPA senior award lecture: making sense of pre-eclampsia - two placental causes of preeclampsia? Placenta 35 (Suppl.), S20\u2013S25 (2014).","journal-title":"Placenta"},{"key":"417_CR138","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11906-022-01184-7","volume":"24","author":"XQ Hu","year":"2022","unstructured":"Hu, X. Q. & Zhang, L. Mitochondrial dysfunction in the pathogenesis of preeclampsia. Curr. Hypertens. Rep. 24, 157\u2013172 (2022).","journal-title":"Curr. Hypertens. Rep."},{"key":"417_CR139","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.3390\/ijms22063132","volume":"22","author":"K Pankiewicz","year":"2021","unstructured":"Pankiewicz, K., Fija\u0142kowska, A., Issat, T. & Maciejewski, T. M. Insight into the key points of preeclampsia pathophysiology: uterine artery remodeling and the role of microRNAs. Int. J. Mol. Sci. 22, 3132 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl. A","key":"417_CR140","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/j.placenta.2008.11.003","volume":"30","author":"GJ Burton","year":"2009","unstructured":"Burton, G. J., Yung, H. W., Cindrova-Davies, T. & Charnock-Jones, D. S. Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta 30 (Suppl. A), S43\u2013S48 (2009).","journal-title":"Placenta"},{"key":"417_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.09.026","author":"AC Staff","year":"2020","unstructured":"Staff, A. C. et al. Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia. Am. J. Obstet. Gynecol. https:\/\/doi.org\/10.1016\/j.ajog.2020.09.026 (2020).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR142","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1006\/bbrc.1998.9719","volume":"252","author":"J Kroll","year":"1998","unstructured":"Kroll, J. & Waltenberger, J. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem. Biophys. Res. Commun. 252, 743\u2013746 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"417_CR143","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1001\/jama.282.4.356","volume":"282","author":"JL Mills","year":"1999","unstructured":"Mills, J. L. et al. Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. JAMA 282, 356\u2013362 (1999).","journal-title":"JAMA"},{"key":"417_CR144","doi-asserted-by":"publisher","first-page":"l2381","DOI":"10.1136\/bmj.l2381","volume":"366","author":"GJ Burton","year":"2019","unstructured":"Burton, G. J., Redman, C. W., Roberts, J. M. & Moffett, A. Pre-eclampsia: pathophysiology and clinical implications. BMJ 366, l2381 (2019).","journal-title":"BMJ"},{"key":"417_CR145","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/HYPERTENSIONAHA.113.01892","volume":"62","author":"F Lyall","year":"2013","unstructured":"Lyall, F., Robson, S. C. & Bulmer, J. N. Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: relationship to clinical outcome. Hypertension 62, 1046\u20131054 (2013).","journal-title":"Hypertension"},{"key":"417_CR146","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/j.1471-0528.1981.tb02222.x","volume":"88","author":"G Gerretsen","year":"1981","unstructured":"Gerretsen, G., Huisjes, H. J. & Elema, J. D. Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. Br. J. Obstet. Gynaecol. 88, 876\u2013881 (1981).","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"417_CR147","first-page":"115","volume":"5","author":"WB Robertson","year":"1976","unstructured":"Robertson, W. B., Brosens, I. & Dixon, G. Maternal uterine vascular lesions in the hypertensive complications of pregnancy. Perspect. Nephrol. Hypertens. 5, 115\u2013127 (1976). This publication identified\u00a0that spiral artery remodelling was impaired in preterm pre-eclampsia.","journal-title":"Perspect. Nephrol. Hypertens."},{"key":"417_CR148","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/j.1471-0528.1977.tb12676.x","volume":"84","author":"I Brosens","year":"1977","unstructured":"Brosens, I., Dixon, H. G. & Robertson, W. B. Fetal growth retardation and the arteries of the placental bed. Br. J. Obstet. Gynaecol. 84, 656\u2013663 (1977).","journal-title":"Br. J. Obstet. Gynaecol."},{"issue":"Suppl. 4","key":"417_CR149","doi-asserted-by":"publisher","first-page":"S9.e1","DOI":"10.1016\/j.ajog.2015.08.003","volume":"213","author":"CW Redman","year":"2015","unstructured":"Redman, C. W. & Staff, A. C. Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity. Am. J. Obstet. Gynecol. 213 (Suppl. 4), S9.e1\u2013S9.e4 (2015).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR150","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/uog.17399","volume":"49","author":"N O\u2019Gorman","year":"2017","unstructured":"O\u2019Gorman, N. et al. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks\u2019 gestation. Ultrasound Obstet. Gynecol. 49, 751\u2013755 (2017).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"417_CR151","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jri.2007.08.002","volume":"76","author":"S Saito","year":"2007","unstructured":"Saito, S., Sakai, M., Sasaki, Y., Nakashima, A. & Shiozaki, A. Inadequate tolerance induction may induce pre-eclampsia. J. Reprod. Immunol. 76, 30\u201339 (2007).","journal-title":"J. Reprod. Immunol."},{"key":"417_CR152","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nri2785","volume":"10","author":"S Sakaguchi","year":"2010","unstructured":"Sakaguchi, S., Miyara, M., Costantino, C. M. & Hafler, D. A. FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 10, 490\u2013500 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"417_CR153","doi-asserted-by":"publisher","first-page":"6561","DOI":"10.1002\/jcp.26604","volume":"233","author":"A Hosseini","year":"2018","unstructured":"Hosseini, A., Dolati, S., Hashemi, V., Abdollahpour-Alitappeh, M. & Yousefi, M. Regulatory T and T helper 17 cells: their roles in preeclampsia. J. Cell. Physiol. 233, 6561\u20136573 (2018).","journal-title":"J. Cell. Physiol."},{"key":"417_CR154","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13475","volume":"86","author":"MA Zolfaghari","year":"2021","unstructured":"Zolfaghari, M. A. et al. T lymphocytes and preeclampsia: The potential role of T-cell subsets and related MicroRNAs in the pathogenesis of preeclampsia. Am. J. Reprod. Immunol. 86, e13475 (2021).","journal-title":"Am. J. Reprod. Immunol."},{"key":"417_CR155","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.it.2006.06.009","volume":"27","author":"IL Sargent","year":"2006","unstructured":"Sargent, I. L., Borzychowski, A. M. & Redman, C. W. NK cells and human pregnancy \u2014 an inflammatory view. Trends Immunol. 27, 399\u2013404 (2006).","journal-title":"Trends Immunol."},{"key":"417_CR156","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.fertnstert.2016.07.1101","volume":"106","author":"SA Robertson","year":"2016","unstructured":"Robertson, S. A. & Sharkey, D. J. Seminal fluid and fertility in women. Fertil. Steril. 106, 511\u2013519 (2016).","journal-title":"Fertil. Steril."},{"key":"417_CR157","doi-asserted-by":"publisher","first-page":"210241","DOI":"10.1155\/2014\/210241","volume":"2014","author":"A Mart\u00ednez-Varea","year":"2014","unstructured":"Mart\u00ednez-Varea, A., Pellicer, B., Perales-Mar\u00edn, A. & Pellicer, A. Relationship between maternal immunological response during pregnancy and onset of preeclampsia. J. Immunol. Res. 2014, 210241 (2014).","journal-title":"J. Immunol. Res."},{"key":"417_CR158","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003494","volume":"95","author":"J Lei","year":"2016","unstructured":"Lei, J. et al. The prognostic role of angiotensin II type 1 receptor autoantibody in non-gravid hypertension and pre-eclampsia: a meta-analysis and our studies. Medicine 95, e3494 (2016).","journal-title":"Medicine"},{"key":"417_CR159","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1161\/HYPERTENSIONAHA.110.162321","volume":"57","author":"K Melchiorre","year":"2011","unstructured":"Melchiorre, K., Sutherland, G. R., Baltabaeva, A., Liberati, M. & Thilaganathan, B. Maternal cardiac dysfunction and remodeling in women with preeclampsia at term. Hypertension 57, 85\u201393 (2011).","journal-title":"Hypertension"},{"key":"417_CR160","doi-asserted-by":"publisher","first-page":"S954","DOI":"10.1016\/j.ajog.2020.10.024","volume":"226","author":"K Melchiorre","year":"2022","unstructured":"Melchiorre, K., Giorgione, V. & Thilaganathan, B. The placenta and preeclampsia: villain or victim? Am. J. Obstet. Gynecol. 226, S954\u2013S962 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR161","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1161\/HYPERTENSIONAHA.118.11191","volume":"73","author":"B Thilaganathan","year":"2019","unstructured":"Thilaganathan, B. & Kalafat, E. Cardiovascular system in preeclampsia and beyond. Hypertension 73, 522\u2013531 (2019).","journal-title":"Hypertension"},{"key":"417_CR162","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/uog.19081","volume":"51","author":"B Thilaganathan","year":"2018","unstructured":"Thilaganathan, B. Pre-eclampsia and the cardiovascular-placental axis. Ultrasound Obstet. Gynecol. 51, 714\u2013717 (2018).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"417_CR163","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/febs.15745","volume":"289","author":"M Hu","year":"2022","unstructured":"Hu, M., Li, J., Baker, P. N. & Tong, C. Revisiting preeclampsia: a metabolic disorder of the placenta. FEBS J. 289, 336\u2013354 (2022).","journal-title":"FEBS J."},{"key":"417_CR164","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1080\/14767058.2016.1185411","volume":"30","author":"RO Bahado-Singh","year":"2017","unstructured":"Bahado-Singh, R. O. et al. Metabolomic determination of pathogenesis of late-onset preeclampsia. J. Matern. Fetal Neonatal Med. 30, 658\u2013664 (2017).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"417_CR165","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/pd.2109","volume":"28","author":"A Farina","year":"2008","unstructured":"Farina, A. et al. Gene expression in chorionic villous samples at 11 weeks\u2019 gestation from women destined to develop preeclampsia. Prenat. Diagn. 28, 956\u2013961 (2008).","journal-title":"Prenat. Diagn."},{"key":"417_CR166","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.placenta.2008.09.015","volume":"30","author":"SA Founds","year":"2009","unstructured":"Founds, S. A. et al. Altered global gene expression in first trimester placentas of women destined to develop preeclampsia. Placenta 30, 15\u201324 (2009).","journal-title":"Placenta"},{"key":"417_CR167","doi-asserted-by":"publisher","first-page":"11682","DOI":"10.1096\/fj.201900662R","volume":"33","author":"MB Rabaglino","year":"2019","unstructured":"Rabaglino, M. B. & Conrad, K. P. Evidence for shared molecular pathways of dysregulated decidualization in preeclampsia and endometrial disorders revealed by microarray data integration. FASEB J. 33, 11682\u201311695 (2019).","journal-title":"FASEB J."},{"key":"417_CR168","doi-asserted-by":"publisher","first-page":"7087","DOI":"10.12659\/MSM.915777","volume":"25","author":"K Jia","year":"2019","unstructured":"Jia, K., Ma, L., Wu, S. & Yang, W. Serum levels of complement factors C1q, Bb, and H in normal pregnancy and severe pre-eclampsia. Med. Sci. Monit. 25, 7087\u20137093 (2019).","journal-title":"Med. Sci. Monit."},{"key":"417_CR169","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.preghy.2019.12.007","volume":"19","author":"KE Vennou","year":"2020","unstructured":"Vennou, K. E., Kontou, P. I., Braliou, G. G. & Bagos, P. G. Meta-analysis of gene expression profiles in preeclampsia. Pregnancy Hypertens. 19, 52\u201360 (2020).","journal-title":"Pregnancy Hypertens."},{"key":"417_CR170","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.7150\/thno.56141","volume":"11","author":"Z Ren","year":"2021","unstructured":"Ren, Z. et al. Distinct placental molecular processes associated with early-onset and late-onset preeclampsia. Theranostics 11, 5028\u20135044 (2021).","journal-title":"Theranostics"},{"key":"417_CR171","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.preghy.2021.05.007","volume":"25","author":"H Saei","year":"2021","unstructured":"Saei, H., Govahi, A., Abiri, A., Eghbali, M. & Abiri, M. Comprehensive transcriptome mining identified the gene expression signature and differentially regulated pathways of the late-onset preeclampsia. Pregnancy Hypertens. 25, 91\u2013102 (2021).","journal-title":"Pregnancy Hypertens."},{"key":"417_CR172","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.placenta.2022.03.009","volume":"125","author":"NG Than","year":"2022","unstructured":"Than, N. G. et al. Early pathways, biomarkers, and four distinct molecular subclasses of preeclampsia: the intersection of clinical, pathological, and high-dimensional biology studies. Placenta 125, 10\u201319 (2022).","journal-title":"Placenta"},{"key":"417_CR173","doi-asserted-by":"publisher","first-page":"3864941","DOI":"10.1155\/2020\/3864941","volume":"2020","author":"M Michalczyk","year":"2020","unstructured":"Michalczyk, M., Celewicz, A., Celewicz, M., Wo\u017aniakowska-Gondek, P. & Rzepka, R. The role of inflammation in the pathogenesis of preeclampsia. Mediators Inflamm. 2020, 3864941 (2020).","journal-title":"Mediators Inflamm."},{"key":"417_CR174","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1586\/eog.10.45","volume":"5","author":"EM George","year":"2010","unstructured":"George, E. M. & Granger, J. P. Recent insights into the pathophysiology of preeclampsia. Expert Rev. Obstet. Gynecol. 5, 557\u2013566 (2010).","journal-title":"Expert Rev. Obstet. Gynecol."},{"key":"417_CR175","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.3390\/ijms22052572","volume":"22","author":"K Matsubara","year":"2021","unstructured":"Matsubara, K., Matsubara, Y., Uchikura, Y. & Sugiyama, T. Pathophysiology of preeclampsia: the role of exosomes. Int. J. Mol. Sci. 22, 2572 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"417_CR176","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/biolre\/ioab060","volume":"105","author":"Z Wang","year":"2021","unstructured":"Wang, Z., Zhao, G., Zeng, M., Feng, W. & Liu, J. Overview of extracellular vesicles in the pathogenesis of preeclampsia. Biol. Reprod. 105, 32\u201339 (2021).","journal-title":"Biol. Reprod."},{"key":"417_CR177","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/aogs.13540","volume":"98","author":"EJ Flint","year":"2019","unstructured":"Flint, E. J., Cerdeira, A. S., Redman, C. W. & Vatish, M. The role of angiogenic factors in the management of preeclampsia. Acta Obstet. Gynecol. Scand. 98, 700\u2013707 (2019).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"417_CR178","doi-asserted-by":"publisher","first-page":"161.e1","DOI":"10.1016\/j.ajog.2009.09.016","volume":"202","author":"S Verlohren","year":"2010","unstructured":"Verlohren, S. et al. An automated method for the determination of the sFlt-1\/PIGF ratio in the assessment of preeclampsia. Am. J. Obstet. Gynecol. 202, 161.e1\u2013161.e11 (2010).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR179","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1172\/JCI17189","volume":"111","author":"SE Maynard","year":"2003","unstructured":"Maynard, S. E. et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111, 649\u2013658 (2003). Publication demonstrating the importance of sFLT1 in the aetiology of pre-eclampsia.","journal-title":"J. Clin. Invest."},{"key":"417_CR180","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nm1429","volume":"12","author":"S Venkatesha","year":"2006","unstructured":"Venkatesha, S. et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat. Med. 12, 642\u2013649 (2006).","journal-title":"Nat. Med."},{"key":"417_CR181","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ejogrb.2021.01.039","volume":"258","author":"G Margioula-Siarkou","year":"2021","unstructured":"Margioula-Siarkou, G. et al. Soluble endoglin concentration in maternal blood as a diagnostic biomarker of preeclampsia: a systematic review and meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 258, 366\u2013381 (2021).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"417_CR182","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041406","author":"P Murthi","year":"2020","unstructured":"Murthi, P., Pinar, A. A., Dimitriadis, E. & Samuel, C. S. Inflammasomes-a molecular link for altered immunoregulation and inflammation mediated vascular dysfunction in preeclampsia. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21041406 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"417_CR183","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13598","volume":"88","author":"M Silber","year":"2022","unstructured":"Silber, M. et al. Inflammasome activation in preeclampsia and intrauterine growth restriction. Am. J. Reprod. Immunol. 88, e13598 (2022).","journal-title":"Am. J. Reprod. Immunol."},{"key":"417_CR184","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm.3893","volume":"21","author":"H Guo","year":"2015","unstructured":"Guo, H., Callaway, J. B. & Ting, J. P. Y. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat. Med. 21, 677\u2013687 (2015).","journal-title":"Nat. Med."},{"key":"417_CR185","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112828","author":"PR Nunes","year":"2021","unstructured":"Nunes, P. R., Mattioli, S. V. & Sandrim, V. C. NLRP3 Activation and its relationship to endothelial dysfunction and oxidative stress: implications for preeclampsia and pharmacological interventions. Cells https:\/\/doi.org\/10.3390\/cells10112828 (2021).","journal-title":"Cells"},{"key":"417_CR186","doi-asserted-by":"publisher","first-page":"15928","DOI":"10.1073\/pnas.1515076112","volume":"112","author":"AL Winship","year":"2015","unstructured":"Winship, A. L. et al. Interleukin-11 alters placentation and causes preeclampsia features in mice. Proc. Natl Acad. Sci. USA 112, 15928\u201315933 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"417_CR187","doi-asserted-by":"publisher","first-page":"784473","DOI":"10.3389\/fimmu.2021.784473","volume":"12","author":"E Menkhorst","year":"2021","unstructured":"Menkhorst, E. et al. Medawar\u2019s PostEra: galectins emerged as key players during fetal-maternal glycoimmune adaptation. Front. Immunol. 12, 784473 (2021).","journal-title":"Front. Immunol."},{"key":"417_CR188","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1161\/HYPERTENSIONAHA.120.15313","volume":"76","author":"E Menkhorst","year":"2020","unstructured":"Menkhorst, E. et al. Galectin-7 impairs placentation and causes preeclampsia features in mice. Hypertension 76, 1185\u20131194 (2020).","journal-title":"Hypertension"},{"key":"417_CR189","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2022.09.008","author":"E Menkhorst","year":"2022","unstructured":"Menkhorst, E. et al. Galectin-7 dysregulates renin-angiotensin-aldosterone and NADPH oxide synthase pathways in preeclampsia. Pregnancy Hypertens. https:\/\/doi.org\/10.1016\/j.preghy.2022.09.008 (2022).","journal-title":"Pregnancy Hypertens."},{"key":"417_CR190","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.placenta.2014.01.009","volume":"35","author":"E Menkhorst","year":"2014","unstructured":"Menkhorst, E., Koga, K., Van Sinderen, M. & Dimitriadis, E. Galectin-7 serum levels are altered prior to the onset of pre-eclampsia. Placenta 35, 281\u2013285 (2014).","journal-title":"Placenta"},{"key":"417_CR191","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.placenta.2016.08.078","volume":"46","author":"P Pillay","year":"2016","unstructured":"Pillay, P., Maharaj, N., Moodley, J. & Mackraj, I. Placental exosomes and pre-eclampsia: maternal circulating levels in normal pregnancies and, early and late onset pre-eclamptic pregnancies. Placenta 46, 18\u201325 (2016).","journal-title":"Placenta"},{"key":"417_CR192","doi-asserted-by":"publisher","first-page":"708824","DOI":"10.3389\/fphys.2021.708824","volume":"12","author":"P Ayala-Ram\u00edrez","year":"2021","unstructured":"Ayala-Ram\u00edrez, P. et al. Assessment of placental extracellular vesicles-associated fas ligand and TNF-related apoptosis-inducing ligand in pregnancies complicated by early and late onset preeclampsia. Front. Physiol. 12, 708824 (2021).","journal-title":"Front. Physiol."},{"key":"417_CR193","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ijgo.2012.07.010","volume":"119","author":"Y Chen","year":"2012","unstructured":"Chen, Y., Huang, Y., Jiang, R. & Teng, Y. Syncytiotrophoblast-derived microparticle shedding in early-onset and late-onset severe pre-eclampsia. Int. J. Gynaecol. Obstet. 119, 234\u2013238 (2012).","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"417_CR194","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113115","author":"Y Feng","year":"2022","unstructured":"Feng, Y. et al. The blocking of integrin-mediated interactions with maternal endothelial cells reversed the endothelial cell dysfunction induced by EVs, derived from preeclamptic placentae. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms232113115 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"417_CR195","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1213\/ANE.0000000000005812","volume":"134","author":"S Murugesan","year":"2022","unstructured":"Murugesan, S. et al. Extracellular vesicles from women with severe preeclampsia impair vascular endothelial function. Anesth. Analg. 134, 713\u2013723 (2022).","journal-title":"Anesth. Analg."},{"key":"417_CR196","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1038\/s41598-017-04468-0","volume":"7","author":"T Cronqvist","year":"2017","unstructured":"Cronqvist, T. et al. Syncytiotrophoblast derived extracellular vesicles transfer functional placental miRNAs to primary human endothelial cells. Sci. Rep. 7, 4558\u20134558 (2017).","journal-title":"Sci. Rep."},{"key":"417_CR197","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/apha.12106","volume":"208","author":"AC Palei","year":"2013","unstructured":"Palei, A. C., Spradley, F. T., Warrington, J. P., George, E. M. & Granger, J. P. Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology. Acta Physiol. 208, 224\u2013233 (2013).","journal-title":"Acta Physiol."},{"key":"417_CR198","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3389\/fphys.2018.00973","volume":"9","author":"Z Armaly","year":"2018","unstructured":"Armaly, Z., Jadaon, J. E., Jabbour, A. & Abassi, Z. A. Preeclampsia: novel mechanisms and potential therapeutic approaches. Front. Physiol. 9, 973 (2018).","journal-title":"Front. Physiol."},{"key":"417_CR199","doi-asserted-by":"publisher","first-page":"S988","DOI":"10.1016\/j.ajog.2021.11.022","volume":"226","author":"W Gyselaers","year":"2022","unstructured":"Gyselaers, W. Hemodynamic pathways of gestational hypertension and preeclampsia. Am. J. Obstet. Gynecol. 226, S988\u2013S1005 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR200","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4274\/tjod.galenos.2019.93708","volume":"16","author":"G \u00d6rg\u00fcl","year":"2019","unstructured":"\u00d6rg\u00fcl, G. et al. First trimester complete blood cell indices in early and late onset preeclampsia. Turk. J. Obstet. Gynecol. 16, 112\u2013117 (2019).","journal-title":"Turk. J. Obstet. Gynecol."},{"key":"417_CR201","first-page":"511","volume":"101","author":"AC Sciscione","year":"2003","unstructured":"Sciscione, A. C. et al. Acute pulmonary edema in pregnancy. Obstet. Gynecol. 101, 511\u2013515 (2003).","journal-title":"Obstet. Gynecol."},{"key":"417_CR202","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011508","volume":"97","author":"ACB Pordeus","year":"2018","unstructured":"Pordeus, A. C. B., Katz, L., Soares, M. C., Maia, S. B. & Amorim, M. M. R. Acute pulmonary edema in an obstetric intensive care unit: a case series study. Medicine 97, e11508 (2018).","journal-title":"Medicine"},{"key":"417_CR203","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ijoa.2017.12.004","volume":"34","author":"T Pretorius","year":"2018","unstructured":"Pretorius, T., van Rensburg, G., Dyer, R. A. & Biccard, B. M. The influence of fluid management on outcomes in preeclampsia: a systematic review and meta-analysis. Int. J. Obstet. Anesth. 34, 85\u201395 (2018).","journal-title":"Int. J. Obstet. Anesth."},{"key":"417_CR204","doi-asserted-by":"publisher","first-page":"327","DOI":"10.4037\/aacnacc2018958","volume":"29","author":"RL Cypher","year":"2018","unstructured":"Cypher, R. L. Pulmonary edema in obstetrics: essential facts for critical care nurses. AACN Adv. Crit. Care 29, 327\u2013335 (2018).","journal-title":"AACN Adv. Crit. Care"},{"key":"417_CR205","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1681\/ASN.2007020255","volume":"18","author":"IE Stillman","year":"2007","unstructured":"Stillman, I. E. & Karumanchi, S. A. The glomerular injury of preeclampsia. J. Am. Soc. Nephrol. 18, 2281\u20132284 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"417_CR206","doi-asserted-by":"publisher","first-page":"320.e1","DOI":"10.1016\/j.ajog.2007.02.007","volume":"196","author":"VD Garovic","year":"2007","unstructured":"Garovic, V. D. et al. Urinary podocyte excretion as a marker for preeclampsia. Am. J. Obstet. Gynecol. 196, 320.e1\u2013320.e7 (2007).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR207","doi-asserted-by":"publisher","first-page":"F1185","DOI":"10.1152\/ajprenal.00442.2007","volume":"294","author":"F Collino","year":"2008","unstructured":"Collino, F. et al. Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells. Am. J. Physiol. Ren. Physiol. 294, F1185\u2013F1194 (2008).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"417_CR208","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMra2109523","volume":"386","author":"LA Magee","year":"2022","unstructured":"Magee, L. A., Nicolaides, K. H. & von Dadelszen, P. Preeclampsia. N. Engl. J. Med. 386, 1817\u20131832 (2022).","journal-title":"N. Engl. J. Med."},{"key":"417_CR209","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.ccc.2004.05.006","volume":"20","author":"JS Steingrub","year":"2004","unstructured":"Steingrub, J. S. Pregnancy-associated severe liver dysfunction. Crit. Care Clin. 20, 763\u2013776 (2004).","journal-title":"Crit. Care Clin."},{"key":"417_CR210","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.12659\/MSM.907723","volume":"24","author":"I Mikolasevic","year":"2018","unstructured":"Mikolasevic, I. et al. Liver disease during pregnancy: a challenging clinical issue. Med. Sci. Monit. 24, 4080\u20134090 (2018).","journal-title":"Med. Sci. Monit."},{"key":"417_CR211","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-9-8","volume":"9","author":"K Haram","year":"2009","unstructured":"Haram, K., Svendsen, E. & Abildgaard, U. The HELLP syndrome: clinical issues and management. A review. BMC Pregnancy Childbirth 9, 8 (2009).","journal-title":"BMC Pregnancy Childbirth"},{"key":"417_CR212","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0002-9378(90)90376-I","volume":"162","author":"BM Sibai","year":"1990","unstructured":"Sibai, B. M. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing. Am. J. Obstet. Gynecol. 162, 311\u2013316 (1990).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR213","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-021-00958-z","volume":"25","author":"EC Miller","year":"2021","unstructured":"Miller, E. C. & Vollbracht, S. Neurology of preeclampsia and related disorders: an update in neuro-obstetrics. Curr. Pain Headache Rep. 25, 40 (2021).","journal-title":"Curr. Pain Headache Rep."},{"key":"417_CR214","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","volume":"33","author":"L Duley","year":"2009","unstructured":"Duley, L. The global impact of pre-eclampsia and eclampsia. Semin. Perinatol. 33, 130\u2013137 (2009).","journal-title":"Semin. Perinatol."},{"key":"417_CR215","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1161\/HYPERTENSIONAHA.118.11513","volume":"74","author":"EC Miller","year":"2019","unstructured":"Miller, E. C. Preeclampsia and cerebrovascular disease. Hypertension 74, 5\u201313 (2019).","journal-title":"Hypertension"},{"key":"417_CR216","doi-asserted-by":"publisher","first-page":"816","DOI":"10.3389\/fneur.2019.00816","volume":"10","author":"D Yousif","year":"2019","unstructured":"Yousif, D. et al. Autonomic dysfunction in preeclampsia: a systematic review. Front. Neurol. 10, 816 (2019).","journal-title":"Front. Neurol."},{"key":"417_CR217","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.preghy.2020.10.013","volume":"23","author":"V Mahendra","year":"2021","unstructured":"Mahendra, V., Clark, S. L. & Suresh, M. S. Neuropathophysiology of preeclampsia and eclampsia: a review of cerebral hemodynamic principles in hypertensive disorders of pregnancy. Pregnancy Hypertens. 23, 104\u2013111 (2021).","journal-title":"Pregnancy Hypertens."},{"key":"417_CR218","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246786","volume":"16","author":"M Andersson","year":"2021","unstructured":"Andersson, M. et al. Signs of neuroaxonal injury in preeclampsia \u2014 a case control study. PLoS ONE 16, e0246786 (2021).","journal-title":"PLoS ONE"},{"key":"417_CR219","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s00404-017-4341-9","volume":"295","author":"LMM Nardozza","year":"2017","unstructured":"Nardozza, L. M. M. et al. Fetal growth restriction: current knowledge. Arch. Gynecol. Obstet. 295, 1061\u20131077 (2017).","journal-title":"Arch. Gynecol. Obstet."},{"key":"417_CR220","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12884-021-04152-2","volume":"21","author":"M Takahashi","year":"2021","unstructured":"Takahashi, M. et al. Fetal growth restriction as the initial finding of preeclampsia is a clinical predictor of maternal and neonatal prognoses: a single-center retrospective study. BMC Pregnancy Childbirth 21, 1\u20138 (2021).","journal-title":"BMC Pregnancy Childbirth"},{"key":"417_CR221","doi-asserted-by":"publisher","first-page":"4108271","DOI":"10.1155\/2019\/4108271","volume":"2019","author":"A Wojtowicz","year":"2019","unstructured":"Wojtowicz, A. et al. Early-and late-onset preeclampsia: a comprehensive cohort study of laboratory and clinical findings according to the new ISHHP criteria. Int. J. Hypertens. 2019, 4108271 (2019).","journal-title":"Int. J. Hypertens."},{"key":"417_CR222","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00404-014-3176-x","volume":"290","author":"R Madazli","year":"2014","unstructured":"Madazli, R. et al. Comparison of clinical and perinatal outcomes in early-and late-onset preeclampsia. Arch. Gynecol. Obstet. 290, 53\u201357 (2014).","journal-title":"Arch. Gynecol. Obstet."},{"key":"417_CR223","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/j.1471-0528.2006.00882.x","volume":"113","author":"M Egbor","year":"2006","unstructured":"Egbor, M., Ansari, T., Morris, N., Green, C. & Sibbons, P. Maternal medicine: morphometric placental villous and vascular abnormalities in early\u2010and late\u2010onset pre\u2010eclampsia with and without fetal growth restriction. BJOG 113, 580\u2013589 (2006).","journal-title":"BJOG"},{"key":"417_CR224","doi-asserted-by":"publisher","first-page":"ix","DOI":"10.3109\/10641950109152635","volume":"20","author":"MA Brown","year":"2001","unstructured":"Brown, M. A., Lindheimer, M. D., de Swiet, M., Van Assche, A. & Moutquin, J. M. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens. Pregnancy 20, ix\u2013xiv (2001).","journal-title":"Hypertens. Pregnancy"},{"key":"417_CR225","doi-asserted-by":"publisher","first-page":"518.e1","DOI":"10.1016\/j.ajog.2020.11.004","volume":"224","author":"J Lai","year":"2021","unstructured":"Lai, J., Syngelaki, A., Nicolaides, K. H., von Dadelszen, P. & Magee, L. A. Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes. Am. J. Obstet. Gynecol. 224, 518.e1\u2013518.e11 (2021).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR226","doi-asserted-by":"publisher","first-page":"217.e1","DOI":"10.1016\/j.ajog.2020.08.019","volume":"224","author":"M Reddy","year":"2021","unstructured":"Reddy, M. et al. The impact of the definition of preeclampsia on disease diagnosis and outcomes: a retrospective cohort study. Am. J. Obstet. Gynecol. 224, 217.e1\u2013217.e11 (2021).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR227","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11906-020-01082-w","volume":"22","author":"RG Sinkey","year":"2020","unstructured":"Sinkey, R. G. et al. Prevention, diagnosis, and management of hypertensive disorders of pregnancy: a comparison of international guidelines. Curr. Hypertens. Rep. 22, 66\u201366 (2020).","journal-title":"Curr. Hypertens. Rep."},{"key":"417_CR228","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","volume":"398","author":"LC Chappell","year":"2021","unstructured":"Chappell, L. C., Cluver, C. A., Kingdom, J. & Tong, S. Pre-eclampsia. Lancet 398, 341\u2013354 (2021).","journal-title":"Lancet"},{"key":"417_CR229","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1161\/HYPERTENSIONAHA.117.10182","volume":"71","author":"S Agrawal","year":"2018","unstructured":"Agrawal, S., Cerdeira, A. S., Redman, C. & Vatish, M. Meta-analysis and systematic review to assess the role of soluble FMS-like tyrosine kinase-1 and placenta growth factor ratio in prediction of preeclampsia: the SaPPPhirE study. Hypertension 71, 306\u2013316 (2018).","journal-title":"Hypertension"},{"key":"417_CR230","first-page":"1","volume":"17","author":"Y Veisani","year":"2019","unstructured":"Veisani, Y., Jenabi, E., Delpisheh, A. & Khazaei, S. Angiogenic factors and the risk of preeclampsia: a systematic review and meta-analysis. Int. J. Reprod. Biomed. 17, 1\u201310 (2019).","journal-title":"Int. J. Reprod. Biomed."},{"key":"417_CR231","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.preghy.2021.02.012","volume":"24","author":"KE Duhig","year":"2021","unstructured":"Duhig, K. E. et al. Prognostic indicators of severe disease in late preterm pre-eclampsia to guide decision making on timing of delivery: the PEACOCK study. Pregnancy Hypertens. 24, 90\u201395 (2021).","journal-title":"Pregnancy Hypertens."},{"key":"417_CR232","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/AOG.0000000000004149","volume":"137","author":"S Lim","year":"2021","unstructured":"Lim, S. et al. Biomarkers and the prediction of adverse outcomes in preeclampsia: a systematic review and meta-analysis. Obstet. Gynecol. 137, 72\u201381 (2021).","journal-title":"Obstet. Gynecol."},{"key":"417_CR233","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00404-015-3671-8","volume":"292","author":"Y Liu","year":"2015","unstructured":"Liu, Y. et al. Diagnostic accuracy of the soluble Fms-like tyrosine kinase-1\/placental growth factor ratio for preeclampsia: a meta-analysis based on 20 studies. Arch. Gynecol. Obstet. 292, 507\u2013518 (2015).","journal-title":"Arch. Gynecol. Obstet."},{"key":"417_CR234","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fmed.2018.00325","volume":"5","author":"EA Huhn","year":"2018","unstructured":"Huhn, E. A. et al. Diagnostic accuracy of different soluble fms-like tyrosine kinase 1 and placental growth factor cut-off values in the assessment of preterm and term preeclampsia: a gestational age matched case-control study. Front. Med. 5, 325\u2013325 (2018).","journal-title":"Front. Med."},{"key":"417_CR235","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/S0140-6736(18)33212-4","volume":"393","author":"KE Duhig","year":"2019","unstructured":"Duhig, K. E. et al. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial. Lancet 393, 1807\u20131818 (2019).","journal-title":"Lancet"},{"key":"417_CR236","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2021.1904393","author":"A Ovayolu","year":"2021","unstructured":"Ovayolu, A. et al. Measuring the status of maternal serum thiol\/disulfide couples in the diagnosis and\/or the determination of the severity of late-onset preeclampsia. J. Matern. Fetal Neonatal Med. https:\/\/doi.org\/10.1080\/14767058.2021.1904393 (2021).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"417_CR237","doi-asserted-by":"publisher","first-page":"15934","DOI":"10.1038\/s41598-021-95611-5","volume":"11","author":"S Cheng","year":"2021","unstructured":"Cheng, S. et al. Novel blood test for early biomarkers of preeclampsia and Alzheimer\u2019s disease. Sci. Rep. 11, 15934\u201315934 (2021).","journal-title":"Sci. Rep."},{"key":"417_CR238","doi-asserted-by":"publisher","DOI":"10.5603\/GP.a2021.0108","author":"N Uzun","year":"2021","unstructured":"Uzun, N., Sar\u0131\u0131brah\u0131m Astepe, B., Uzun, F. & Kale, E. Predictive value of maternal serum podocalyxin in the diagnosis of preeclampsia: a prospective case-control study. Ginekol. Pol. https:\/\/doi.org\/10.5603\/GP.a2021.0108 (2021).","journal-title":"Ginekol. Pol."},{"key":"417_CR239","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/0002-9378(93)90043-I","volume":"169","author":"BM Sibai","year":"1993","unstructured":"Sibai, B. M. et al. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am. J. Obstet. Gynecol. 169, 1000\u20131006 (1993).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR240","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1136\/bmj.309.6966.1395","volume":"309","author":"KA Douglas","year":"1994","unstructured":"Douglas, K. A. & Redman, C. W. Eclampsia in the United Kingdom. BMJ 309, 1395\u20131400 (1994).","journal-title":"BMJ"},{"key":"417_CR241","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/aogs.13051","volume":"96","author":"EF Zwertbroek","year":"2017","unstructured":"Zwertbroek, E. F. et al. Prediction of progression to severe disease in women with late preterm hypertensive disorders of pregnancy. Acta Obstet. Gynecol. Scand. 96, 96\u2013105 (2017).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"417_CR242","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0140-6736(10)61351-7","volume":"377","author":"P von Dadelszen","year":"2011","unstructured":"von Dadelszen, P. et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet 377, 219\u2013227 (2011).","journal-title":"Lancet"},{"key":"417_CR243","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0140-6736(09)60736-4","volume":"374","author":"CM Koopmans","year":"2009","unstructured":"Koopmans, C. M. et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks\u2019 gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 374, 979\u2013988 (2009).","journal-title":"Lancet"},{"key":"417_CR244","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1016\/S0140-6736(14)61998-X","volume":"385","author":"K Broekhuijsen","year":"2015","unstructured":"Broekhuijsen, K. et al. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. Lancet 385, 2492\u20132501 (2015).","journal-title":"Lancet"},{"key":"417_CR245","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1161\/HYPERTENSIONAHA.119.12760","volume":"74","author":"X Bian","year":"2019","unstructured":"Bian, X. et al. Short-term prediction of adverse outcomes using the sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor) ratio in Asian women with suspected preeclampsia. Hypertension 74, 164\u2013172 (2019).","journal-title":"Hypertension"},{"key":"417_CR246","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/uog.24851","volume":"59","author":"M Reddy","year":"2022","unstructured":"Reddy, M. et al. Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre-eclampsia. Ultrasound Obstet. Gynecol. 59, 596\u2013605 (2022).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"417_CR247","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1161\/HYPERTENSIONAHA.117.10318","volume":"71","author":"UV Ukah","year":"2018","unstructured":"Ukah, U. V. et al. Assessment of the fullPIERS risk prediction model in women with early-onset preeclampsia. Hypertension 71, 659\u2013665 (2018).","journal-title":"Hypertension"},{"key":"417_CR248","doi-asserted-by":"publisher","first-page":"103.e1","DOI":"10.1016\/j.ajog.2015.08.034","volume":"214","author":"N O\u2019Gorman","year":"2016","unstructured":"O\u2019Gorman, N. et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11\u201313 weeks gestation. Am. J. Obstet. Gynecol. 214, 103.e1\u2013103.e12 (2016).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR249","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/uog.19112","volume":"52","author":"MY Tan","year":"2018","unstructured":"Tan, M. Y. et al. Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks\u2019 gestation. Ultrasound Obstet. Gynecol. 52, 186\u2013195 (2018).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"417_CR250","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ajog.2019.11.1247","volume":"223","author":"D Wright","year":"2020","unstructured":"Wright, D., Wright, A. & Nicolaides, K. H. The competing risk approach for prediction of preeclampsia. Am. J. Obstet. Gynecol. 223,\u00a012\u201323.e17 (2020).","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"Suppl. 1","key":"417_CR251","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijgo.12802","volume":"145","author":"LC Poon","year":"2019","unstructured":"Poon, L. C. et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int. J. Gynaecol. Obstet. 145 (Suppl. 1), 1\u201333 (2019).","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"417_CR252","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.14049","author":"DL Rolnik","year":"2021","unstructured":"Rolnik, D. L. et al. Routine first trimester combined screening for preterm preeclampsia in Australia: a multicenter clinical implementation cohort study. Int. J. Gynaecol. Obstet. https:\/\/doi.org\/10.1002\/ijgo.14049 (2021).","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"417_CR253","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/uog.22193","volume":"58","author":"F Park","year":"2021","unstructured":"Park, F., Deeming, S., Bennett, N. & Hyett, J. Cost-effectiveness analysis of a model of first-trimester prediction and prevention of preterm pre-eclampsia compared with usual care. Ultrasound Obstet. Gynecol. 58, 688\u2013697 (2021).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"417_CR254","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/uog.20105","volume":"53","author":"A Sotiriadis","year":"2019","unstructured":"Sotiriadis, A. et al. ISUOG Practice Guidelines: role of ultrasound in screening for and follow-up of pre-eclampsia. Ultrasound Obstet. Gynecol. 53, 7\u201322 (2019).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"417_CR255","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/uog.19099","volume":"52","author":"M Litwinska","year":"2018","unstructured":"Litwinska, M., Syngelaki, A., Wright, A., Wright, D. & Nicolaides, K. H. Management of pregnancies after combined screening for pre-eclampsia at 19\u201324 weeks\u2019 gestation. Ultrasound Obstet. Gynecol. 52, 365\u2013372 (2018).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"417_CR256","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/ajo.13113","volume":"60","author":"C Black","year":"2020","unstructured":"Black, C. et al. Prediction of preterm pre-eclampsia at midpregnancy using a multivariable screening algorithm. Aust. NZ J. Obstet. Gynaecol. 60, 675\u2013682 (2020).","journal-title":"Aust. NZ J. Obstet. Gynaecol."},{"key":"417_CR257","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/uog.17309","volume":"49","author":"D Wright","year":"2017","unstructured":"Wright, D., Dragan, I., Syngelaki, A., Akolekar, R. & Nicolaides, K. H. Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 30\u201334 weeks\u2019 gestation. Ultrasound Obstet. Gynecol. 49, 194\u2013200 (2017).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"417_CR258","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/uog.19111","volume":"52","author":"A Panaitescu","year":"2018","unstructured":"Panaitescu, A. et al. Screening for pre-eclampsia at 35\u201337 weeks\u2019 gestation. Ultrasound Obstet. Gynecol. 52, 501\u2013506 (2018).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"417_CR259","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1159\/000497144","volume":"46","author":"SSY Teoh","year":"2019","unstructured":"Teoh, S. S. Y. et al. Low serum levels of HtrA3 at 15 weeks of gestation are associated with late-onset preeclampsia development and small for gestational age birth. Fetal Diagn. Ther. 46, 392\u2013401 (2019).","journal-title":"Fetal Diagn. Ther."},{"key":"417_CR260","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41586-021-04249-w","volume":"601","author":"M Rasmussen","year":"2022","unstructured":"Rasmussen, M. et al. RNA profiles reveal signatures of future health and disease in pregnancy. Nature 601, 422\u2013427 (2022). This paper demonstrates that circulating placental RNA can predict pre-eclampsia risk, which has exciting potential as a predictive biomarker.","journal-title":"Nature"},{"key":"417_CR261","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41586-022-04410-z","volume":"602","author":"MN Moufarrej","year":"2022","unstructured":"Moufarrej, M. N. et al. Early prediction of preeclampsia in pregnancy with cell-free RNA. Nature 602, 689\u2013694 (2022).","journal-title":"Nature"},{"key":"417_CR262","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/14767058.2018.1484089","volume":"33","author":"B Panaitescu","year":"2020","unstructured":"Panaitescu, B. et al. ELABELA plasma concentrations are increased in women with late-onset preeclampsia. J. Matern. Fetal Neonatal Med. 33, 5\u201315 (2020).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"417_CR263","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1080\/14767058.2017.1333098","volume":"31","author":"E Alici Davuto\u011flu","year":"2018","unstructured":"Alici Davuto\u011flu, E. et al. Evaluation of maternal serum hypoxia inducible factor-1\u03b1, progranulin and syndecan-1 levels in pregnancies with early- and late-onset preeclampsia. J. Matern. Fetal Neonatal Med. 31, 1976\u20131982 (2018).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"417_CR264","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/S0140-6736(85)92207-X","volume":"1","author":"M Beaufils","year":"1985","unstructured":"Beaufils, M., Uzan, S., Donsimoni, R. & Colau, J. C. Prevention of pre-eclampsia by early antiplatelet therapy. Lancet 1, 840\u2013842 (1985).","journal-title":"Lancet"},{"key":"417_CR265","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/0002-9378(93)90351-I","volume":"168","author":"JC Hauth","year":"1993","unstructured":"Hauth, J. C. et al. Low-dose aspirin therapy to prevent preeclampsia. Am. J. Obstet. Gynecol. 168, 1083\u20131091 (1993).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR266","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1001\/jama.1991.03470020086038","volume":"266","author":"TF Imperiale","year":"1991","unstructured":"Imperiale, T. F. & Petrulis, A. S. A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. JAMA 266, 260\u2013264 (1991).","journal-title":"JAMA"},{"key":"417_CR267","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0140-6736(86)91891-X","volume":"327","author":"HCS Wallenburg","year":"1986","unstructured":"Wallenburg, H. C. S., Makovitz, J. W., Dekker, G. A. & Rotmans, P. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet 327, 1\u20133 (1986).","journal-title":"Lancet"},{"key":"417_CR268","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","volume":"369","author":"LM Askie","year":"2007","unstructured":"Askie, L. M., Duley, L., Henderson-Smart, D. J. & Stewart, L. A. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 369, 1791\u20131798 (2007).","journal-title":"Lancet"},{"key":"417_CR269","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.17222","author":"M-LW Kinshella","year":"2022","unstructured":"Kinshella, M.-L. W. et al. Calcium for pre-eclampsia prevention: a systematic review and network meta-analysis to guide personalised antenatal care. BJOG https:\/\/doi.org\/10.1111\/1471-0528.17222 (2022).","journal-title":"BJOG"},{"key":"417_CR270","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa1800566","volume":"379","author":"WA Grobman","year":"2018","unstructured":"Grobman, W. A. et al. Labor induction versus expectant management in low-risk nulliparous women. N. Engl. J. Med. 379, 513\u2013523 (2018).","journal-title":"N. Engl. J. Med."},{"key":"417_CR271","doi-asserted-by":"publisher","DOI":"10.1055\/a-1798-1925","author":"MI Aldika Akbar","year":"2022","unstructured":"Aldika Akbar, M. I. et al. INOVASIA study: a multicenter randomized clinical trial of pravastatin to prevent preeclampsia in high risk patients. Am. J. Perinatol. https:\/\/doi.org\/10.1055\/a-1798-1925 (2022).","journal-title":"Am. J. Perinatol."},{"key":"417_CR272","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1161\/CIRCULATIONAHA.121.053963","volume":"144","author":"M D\u00f6bert","year":"2021","unstructured":"D\u00f6bert, M. et al. Pravastatin versus placebo in pregnancies at high risk of term preeclampsia. Circulation 144, 670\u2013679 (2021).","journal-title":"Circulation"},{"key":"417_CR273","doi-asserted-by":"publisher","first-page":"9240","DOI":"10.1038\/s41598-021-88650-5","volume":"11","author":"JL Tarry-Adkins","year":"2021","unstructured":"Tarry-Adkins, J. L., Ozanne, S. E. & Aiken, C. E. Impact of metformin treatment during pregnancy on maternal outcomes: a systematic review\/meta-analysis. Sci. Rep. 11, 9240 (2021).","journal-title":"Sci. Rep."},{"key":"417_CR274","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1056\/NEJMoa1509819","volume":"374","author":"A Syngelaki","year":"2016","unstructured":"Syngelaki, A. et al. Metformin versus placebo in obese pregnant women without diabetes mellitus. N. Engl. J. Med. 374, 434\u2013443 (2016).","journal-title":"N. Engl. J. Med."},{"key":"417_CR275","first-page":"174550572211110","volume":"18","author":"R Irwinda","year":"2022","unstructured":"Irwinda, R., Hiksas, R., Lokeswara, A. W. & Wibowo, N. Vitamin D supplementation higher than 2000\u2009IU\/day compared to lower dose on maternal-fetal outcome: systematic review and meta-analysis. Womens Health 18, 17455057221111066 (2022).","journal-title":"Womens Health"},{"key":"417_CR276","doi-asserted-by":"publisher","first-page":"S1126","DOI":"10.1016\/j.ajog.2020.11.006","volume":"226","author":"M Cruz-Lemini","year":"2022","unstructured":"Cruz-Lemini, M., V\u00e1zquez, J. C., Ullmo, J. & Llurba, E. Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. 226, S1126\u2013S1144.e17 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR277","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ajog.2011.07.017","volume":"205","author":"BM Sibai","year":"2011","unstructured":"Sibai, B. M. Evaluation and management of severe preeclampsia before 34 weeks\u2019 gestation. Am. J. Obstet. Gynecol. 205, 191\u2013198 (2011).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR278","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0140-6736(19)31282-6","volume":"394","author":"T Easterling","year":"2019","unstructured":"Easterling, T. et al. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial. Lancet 394, 1011\u20131021 (2019).","journal-title":"Lancet"},{"key":"417_CR279","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.14406","author":"SW Nij Bijvank","year":"2022","unstructured":"Nij Bijvank, S. W. et al. Nicardipine for treating severe antepartum hypertension during pregnancy: Nine years of experience in more than 800 women. Acta Obstet. Gynecol. Scand. https:\/\/doi.org\/10.1111\/aogs.14406 (2022).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"417_CR280","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1111\/j.1471-0528.1993.tb15120.x","volume":"100","author":"L Impey","year":"1993","unstructured":"Impey, L. Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks. Br. J. Obstet. Gynaecol. 100, 959\u2013961 (1993).","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"417_CR281","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1517\/14740338.2015.998197","volume":"14","author":"LA Magee","year":"2015","unstructured":"Magee, L. A., Namouz-Haddad, S., Cao, V., Koren, G. & von Dadelszen, P. Labetalol for hypertension in pregnancy. Expert Opin. Drug Saf. 14, 453\u2013461 (2015).","journal-title":"Expert Opin. Drug Saf."},{"key":"417_CR282","doi-asserted-by":"publisher","first-page":"110196","DOI":"10.1016\/j.biopha.2020.110196","volume":"127","author":"M Wici\u0144ski","year":"2020","unstructured":"Wici\u0144ski, M., Malinowski, B., Puk, O., Socha, M. & S\u0142upski, M. Methyldopa as an inductor of postpartum depression and maternal blues: a review. Biomed. Pharmacother. 127, 110196 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"417_CR283","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1404595","volume":"372","author":"LA Magee","year":"2015","unstructured":"Magee, L. A. et al. Less-tight versus tight control of hypertension in pregnancy. N. Engl. J. Med. 372, 407\u2013417 (2015).","journal-title":"N. Engl. J. Med."},{"key":"417_CR284","first-page":"CD002252","volume":"10","author":"E Abalos","year":"2018","unstructured":"Abalos, E., Duley, L., Steyn, D. W. & Gialdini, C. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst. Rev. 10, CD002252 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"417_CR285","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/S0140-6736(19)31963-4","volume":"394","author":"LC Chappell","year":"2019","unstructured":"Chappell, L. C. et al. Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial. Lancet 394, 1181\u20131190 (2019).","journal-title":"Lancet"},{"key":"417_CR286","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ajog.2022.04.034","volume":"227","author":"A Beardmore-Gray","year":"2022","unstructured":"Beardmore-Gray, A. et al. Planned delivery or expectant management in preeclampsia: an individual participant data meta-analysis. Am. J. Obstet. Gynecol. 227, 218\u2013230.e8 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR287","doi-asserted-by":"publisher","first-page":"585.e1","DOI":"10.1016\/j.ajog.2017.07.038","volume":"217","author":"LC Poon","year":"2017","unstructured":"Poon, L. C. et al. Aspirin for evidence-based preeclampsia prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. Am. J. Obstet. Gynecol. 217, 585.e1\u2013585.e5 (2017).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR288","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1161\/HYPERTENSIONAHA.112.196352","volume":"60","author":"M Bullo","year":"2012","unstructured":"Bullo, M., Tschumi, S., Bucher, B. S., Bianchetti, M. G. & Simonetti, G. D. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review. Hypertension 60, 444\u2013450 (2012).","journal-title":"Hypertension"},{"key":"417_CR289","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.Cd002960","author":"L Duley","year":"2001","unstructured":"Duley, L. & Gulmezoglu, A. M. Magnesium sulphate versus lytic cocktail for eclampsia. Cochrane Database Syst. Rev. https:\/\/doi.org\/10.1002\/14651858.Cd002960 (2001).","journal-title":"Cochrane Database Syst. Rev."},{"key":"417_CR290","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/S0140-6736(02)08778-0","volume":"359","author":"D Altman","year":"2002","unstructured":"Altman, D. et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie trial: a randomised placebo-controlled trial. Lancet 359, 1877\u20131890 (2002).","journal-title":"Lancet"},{"key":"417_CR291","doi-asserted-by":"publisher","first-page":"136","DOI":"10.4103\/IJCIIS.IJCIIS_33_17","volume":"7","author":"MTC Lam","year":"2017","unstructured":"Lam, M. T. C. & Dierking, E. Intensive care unit issues in eclampsia and HELLP syndrome. Int. J. Crit. Illn. Inj. Sci. 7, 136\u2013141 (2017).","journal-title":"Int. J. Crit. Illn. Inj. Sci."},{"key":"417_CR292","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1161\/CIR.0b013e31820faaf8","volume":"123","author":"L Mosca","year":"2011","unstructured":"Mosca, L. et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women\u20132011 update: a guideline from the American Heart Association. Circulation 123, 1243\u20131262 (2011).","journal-title":"Circulation"},{"key":"417_CR293","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1089\/jwh.2020.8384","volume":"30","author":"EW Seely","year":"2021","unstructured":"Seely, E. W. et al. Cardiovascular health after preeclampsia: patient and provider perspective. J. Womens Health 30, 305\u2013313 (2021).","journal-title":"J. Womens Health"},{"key":"417_CR294","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1161\/HYPERTENSIONAHA.118.10911","volume":"72","author":"AE Cairns","year":"2018","unstructured":"Cairns, A. E. et al. Self-management of postnatal hypertension: the SNAP-HT trial. Hypertension 72, 425\u2013432 (2018).","journal-title":"Hypertension"},{"key":"417_CR295","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1161\/HYPERTENSIONAHA.120.17101","volume":"78","author":"JA Kitt","year":"2021","unstructured":"Kitt, J. A. et al. Short-term postpartum blood pressure self-management and long-term blood pressure control: a randomized controlled trial. Hypertension 78, 469\u2013479 (2021).","journal-title":"Hypertension"},{"key":"417_CR296","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1161\/HYPERTENSIONAHA.110.150078","volume":"56","author":"ML Mongraw-Chaffin","year":"2010","unstructured":"Mongraw-Chaffin, M. L., Cirillo, P. M. & Cohn, B. A. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension 56, 166\u2013171 (2010).","journal-title":"Hypertension"},{"key":"417_CR297","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/uog.22107","volume":"57","author":"A Dall\u2019Asta","year":"2021","unstructured":"Dall\u2019Asta, A. et al. Cardiovascular events following pregnancy complicated by pre\u2010eclampsia with emphasis on comparison between early\u2010and late\u2010onset forms: systematic review and meta\u2010analysis. Ultrasound Obstet. Gynecol. 57, 698\u2013709 (2021).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"417_CR298","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1089\/jwh.2018.7523","volume":"28","author":"JW Rich-Edwards","year":"2019","unstructured":"Rich-Edwards, J. W. et al. Randomized trial to reduce cardiovascular risk in women with recent preeclampsia. J. Womens Health 28, 1493\u20131504 (2019).","journal-title":"J. Womens Health"},{"key":"417_CR299","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1042\/CS20150567","volume":"130","author":"ND Paauw","year":"2016","unstructured":"Paauw, N. D., Luijken, K., Franx, A., Verhaar, M. C. & Lely, A. T. Long-term renal and cardiovascular risk after preeclampsia: towards screening and prevention. Clin. Sci. 130, 239\u2013246 (2016).","journal-title":"Clin. Sci."},{"key":"417_CR300","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1056\/NEJMoa0706790","volume":"359","author":"BE Vikse","year":"2008","unstructured":"Vikse, B. E., Irgens, L. M., Leivestad, T., Skj\u00e6rven, R. & Iversen, B. M. Preeclampsia and the risk of end-stage renal disease. N. Engl. J. Med. 359, 800\u2013809 (2008).","journal-title":"N. Engl. J. Med."},{"key":"417_CR301","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1080\/13803395.2016.1143453","volume":"38","author":"IR Postma","year":"2016","unstructured":"Postma, I. R. et al. Cerebral white matter lesions, subjective cognitive failures, and objective neurocognitive functioning: a follow-up study in women after hypertensive disorders of pregnancy. J. Clin. Exp. Neuropsychol. 38, 585\u2013598 (2016).","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"417_CR302","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1093\/ajh\/hpab112","volume":"34","author":"VR Nuckols","year":"2021","unstructured":"Nuckols, V. R. et al. Twenty-four-hour blood pressure variability is associated with lower cognitive performance in young women with a recent history of preeclampsia. Am. J. Hypertens. 34, 1291\u20131299 (2021).","journal-title":"Am. J. Hypertens."},{"key":"417_CR303","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/bmj.39335.385301.BE","volume":"335","author":"L Bellamy","year":"2007","unstructured":"Bellamy, L., Casas, J.-P., Hingorani, A. D. & Williams, D. J. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 335, 974 (2007).","journal-title":"BMJ"},{"key":"417_CR304","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1111\/j.1471-0528.2012.03406.x","volume":"119","author":"A Aukes","year":"2012","unstructured":"Aukes, A. et al. Long\u2010term cerebral imaging after pre\u2010eclampsia. BJOG 119, 1117\u20131122 (2012).","journal-title":"BJOG"},{"key":"417_CR305","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-015-0575-8","volume":"17","author":"ES Hammer","year":"2015","unstructured":"Hammer, E. S. & Cipolla, M. J. Cerebrovascular dysfunction in preeclamptic pregnancies. Curr. Hypertens. Rep. 17, 1\u20138 (2015).","journal-title":"Curr. Hypertens. Rep."},{"key":"417_CR306","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/OGX.0000000000000069","volume":"69","author":"IR Postma","year":"2014","unstructured":"Postma, I. R., Slager, S., Kremer, H. P., de Groot, J. C. & Zeeman, G. G. Long-term consequences of the posterior reversible encephalopathy syndrome in eclampsia and preeclampsia: a review of the obstetric and nonobstetric literature. Obstet. Gynecol. Surv. 69, 287\u2013300 (2014).","journal-title":"Obstet. Gynecol. Surv."},{"key":"417_CR307","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1097\/GME.0000000000001806","volume":"28","author":"F Wang","year":"2021","unstructured":"Wang, F., Zhang, W., Cheng, W., Huo, N. & Zhang, S. Preeclampsia and cancer risk in women in later life: a systematic review and meta-analysis of cohort studies. Menopause 28, 1070\u20131078 (2021).","journal-title":"Menopause"},{"key":"417_CR308","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3390\/biom11111625","volume":"11","author":"M Benagiano","year":"2021","unstructured":"Benagiano, M., Mancuso, S., Brosens, J. J. & Benagiano, G. Long-term consequences of placental vascular pathology on the maternal and offspring cardiovascular systems. Biomolecules 11, 1625 (2021).","journal-title":"Biomolecules"},{"key":"417_CR309","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.semnephrol.2010.10.010","volume":"31","author":"D Williams","year":"2011","unstructured":"Williams, D. Long-term complications of preeclampsia. Semin. Nephrol. 31, 111\u2013122 (2011).","journal-title":"Semin. Nephrol."},{"key":"417_CR310","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.echo.2021.01.008","volume":"34","author":"Z Hoodbhoy","year":"2021","unstructured":"Hoodbhoy, Z. et al. Cardiovascular dysfunction in children exposed to preeclampsia during fetal life. J. Am. Soc. Echocardiogr. 34, 653\u2013661 (2021).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"417_CR311","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1161\/HYPERTENSIONAHA.112.198366","volume":"60","author":"M Lazdam","year":"2012","unstructured":"Lazdam, M. et al. Unique blood pressure characteristics in mother and offspring after early onset preeclampsia. Hypertension 60, 1338\u20131345 (2012).","journal-title":"Hypertension"},{"key":"417_CR312","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2011.02.032","volume":"204","author":"AG van Wassenaer","year":"2011","unstructured":"van Wassenaer, A. G. et al. Outcome at 4.5 years of children born after expectant management of early-onset hypertensive disorders of pregnancy. Am. J. Obstet. Gynecol. 204, e1\u2013e9 (2011).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR313","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s11136-013-0525-3","volume":"23","author":"C Stern","year":"2014","unstructured":"Stern, C. et al. The impact of severe preeclampsia on maternal quality of life. Qual. Life Res. 23, 1019\u20131026 (2014).","journal-title":"Qual. Life Res."},{"key":"417_CR314","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1080\/14767058.2016.1254185","volume":"30","author":"O Cetin","year":"2017","unstructured":"Cetin, O., Guzel Ozdemir, P., Kurdoglu, Z. & Sahin, H. G. Investigation of maternal psychopathological symptoms, dream anxiety and insomnia in preeclampsia. J. Matern. Fetal Neonatal Med. 30, 2510\u20132515 (2017).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"417_CR315","doi-asserted-by":"publisher","first-page":"158.e1","DOI":"10.1016\/j.ajog.2007.03.045","volume":"197","author":"A Rep","year":"2007","unstructured":"Rep, A., Ganzevoort, W., Bonsel, G. J., Wolf, H. & de Vries, J. I. Psychosocial impact of early-onset hypertensive disorders and related complications in pregnancy. Am. J. Obstet. Gynecol. 197, 158.e1\u2013158.e6 (2007).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR316","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1089\/jwh.2010.2584","volume":"20","author":"M Hoedjes","year":"2011","unstructured":"Hoedjes, M. et al. Postpartum depression after mild and severe preeclampsia. J. Womens Health 20, 1535\u20131542 (2011).","journal-title":"J. Womens Health"},{"key":"417_CR317","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1523-536X.2011.00477.x","volume":"38","author":"M Hoedjes","year":"2011","unstructured":"Hoedjes, M. et al. Poor health\u2010related quality of life after severe preeclampsia. Birth 38, 246\u2013255 (2011).","journal-title":"Birth"},{"key":"417_CR318","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3109\/0167482X.2011.599460","volume":"32","author":"M Hoedjes","year":"2011","unstructured":"Hoedjes, M. et al. Symptoms of post-traumatic stress after preeclampsia. J. Psychosom. Obstet. Gynaecol. 32, 126\u2013134 (2011).","journal-title":"J. Psychosom. Obstet. Gynaecol."},{"key":"417_CR319","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3109\/14767058.2011.573829","volume":"25","author":"IP Gaugler-Senden","year":"2012","unstructured":"Gaugler-Senden, I. P. et al. Maternal psychosocial outcome after early onset preeclampsia and preterm birth. J. Matern. Fetal Neonatal Med. 25, 272\u2013276 (2012).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"417_CR320","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqac096","author":"EB Taylor","year":"2022","unstructured":"Taylor, E. B. & George, E. M. Animal models of preeclampsia: mechanistic insights and promising therapeutics. Endocrinology https:\/\/doi.org\/10.1210\/endocr\/bqac096 (2022).","journal-title":"Endocrinology"},{"key":"417_CR321","doi-asserted-by":"publisher","first-page":"681632","DOI":"10.3389\/fphys.2021.681632","volume":"12","author":"CA Waker","year":"2021","unstructured":"Waker, C. A., Kaufman, M. R. & Brown, T. L. Current state of preeclampsia mouse models: approaches, relevance, and standardization. Front. Physiol. 12, 681632 (2021).","journal-title":"Front. Physiol."},{"key":"417_CR322","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/hy02t2.102904","volume":"39","author":"RL Davisson","year":"2002","unstructured":"Davisson, R. L. et al. Discovery of a spontaneous genetic mouse model of preeclampsia. Hypertension 39, 337\u2013342 (2002).","journal-title":"Hypertension"},{"key":"417_CR323","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1073\/pnas.1011293108","volume":"108","author":"K Kumasawa","year":"2011","unstructured":"Kumasawa, K. et al. Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model. Proc. Natl Acad. Sci. USA 108, 1451\u20131455 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"417_CR324","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1126\/science.274.5289.995","volume":"274","author":"E Takimoto","year":"1996","unstructured":"Takimoto, E. et al. Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science 274, 995\u2013998 (1996).","journal-title":"Science"},{"key":"417_CR325","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1681\/ASN.V11112056","volume":"11","author":"J Bohlender","year":"2000","unstructured":"Bohlender, J., Ganten, D. & Luft, F. C. Rats transgenic for human renin and human angiotensinogen as a model for gestational hypertension. J. Am. Soc. Nephrol. 11, 2056 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"417_CR326","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1161\/HYPERTENSIONAHA.111.202994","volume":"61","author":"L Doridot","year":"2013","unstructured":"Doridot, L. et al. Preeclampsia-like symptoms induced in mice by fetoplacental expression of STOX1 are reversed by aspirin treatment. Hypertension\u00a061, 662\u2013668 (2013).","journal-title":"Hypertension"},{"key":"417_CR327","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1161\/HYPERTENSIONAHA.111.175919","volume":"58","author":"J Singh","year":"2011","unstructured":"Singh, J., Ahmed, A. & Girardi, G. Role of complement component C1q in the onset of preeclampsia in mice. Hypertension 58, 716\u2013724 (2011).","journal-title":"Hypertension"},{"key":"417_CR328","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1161\/01.HYP.37.4.1191","volume":"37","author":"BT Alexander","year":"2001","unstructured":"Alexander, B. T. et al. Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. Hypertension 37, 1191\u20131195 (2001).","journal-title":"Hypertension"},{"key":"417_CR329","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0002-9378(74)90360-3","volume":"120","author":"D Cavanagh","year":"1974","unstructured":"Cavanagh, D., Rao, P. S., Tung, K. S. K. & Gaston, L. Eclamptogenic toxemia: the development of an experimental model in the subhuman primate. Am. J. Obstet. Gynecol. 120, 183\u2013196 (1974).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR330","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/0002-9378(93)90299-X","volume":"169","author":"C Yallampalli","year":"1993","unstructured":"Yallampalli, C. & Garfield, R. E. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am. J. Obstet. Gynecol. 169, 1316\u20131320 (1993).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"417_CR331","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3389\/fphys.2019.01030","volume":"10","author":"M Fan","year":"2019","unstructured":"Fan, M. et al. LPS induces preeclampsia-like phenotype in rats and HTR8\/SVneo cells dysfunction through TLR4\/p38 MAPK pathway. Front. Physiol. 10, 1030 (2019).","journal-title":"Front. Physiol."},{"key":"417_CR332","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1182\/blood-2016-03-705434","volume":"128","author":"S Kohli","year":"2016","unstructured":"Kohli, S. et al. Maternal extracellular vesicles and platelets promote preeclampsia via inflammasome activation in trophoblasts. Blood 128, 2153\u20132164 (2016).","journal-title":"Blood"},{"key":"417_CR333","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.2353\/ajpath.2010.100475","volume":"177","author":"S Kalkunte","year":"2010","unstructured":"Kalkunte, S. et al. Sera from preeclampsia patients elicit symptoms of human disease in mice and provide a basis for an in vitro predictive assay. Am. J. Pathol. 177, 2387\u20132398 (2010).","journal-title":"Am. J. Pathol."},{"key":"417_CR334","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejogrb.2014.08.021","volume":"182","author":"S Baijnath","year":"2014","unstructured":"Baijnath, S., Soobryan, N., Mackraj, I., Gathiram, P. & Moodley, J. The optimization of a chronic nitric oxide synthase (NOS) inhibition model of pre-eclampsia by evaluating physiological changes. Eur. J. Obstet. Gynecol. Reprod. Biol. 182, 71\u201375 (2014).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"417_CR335","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejphar.2016.12.010","volume":"795","author":"N Soobryan","year":"2017","unstructured":"Soobryan, N. et al. The effects of sildenafil citrate on uterine angiogenic status and serum inflammatory markers in an L-NAME rat model of pre-eclampsia. Eur. J. Pharmacol. 795, 101\u2013107 (2017).","journal-title":"Eur. J. Pharmacol."},{"key":"417_CR336","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11010-016-2897-5","volume":"427","author":"S Baijnath","year":"2017","unstructured":"Baijnath, S., Murugesan, S., Mackraj, I., Gathiram, P. & Moodley, J. The effects of sildenafil citrate on urinary podocin and nephrin mRNA expression in an L-NAME model of pre-eclampsia. Mol. Cell Biochem. 427, 59\u201367 (2017).","journal-title":"Mol. Cell Biochem."},{"key":"417_CR337","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s00210-016-1296-5","volume":"389","author":"JS Possomato-Vieira","year":"2016","unstructured":"Possomato-Vieira, J. S., Gon\u00e7alves-Rizzi, V. H., Gra\u00e7a, T. U., Nascimento, R. A. & Dias-Junior, C. A. Sodium hydrosulfide prevents hypertension and increases in vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 in hypertensive pregnant rats. Naunyn Schmiedebergs Arch. Pharmacol. 389, 1325\u20131332 (2016).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"417_CR338","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.pathophys.2018.08.001","volume":"25","author":"GO Oludare","year":"2018","unstructured":"Oludare, G. O., Jinadu, H. D. & Aro, O. O. L-arginine attenuates blood pressure and reverses the suppression of angiogenic risk factors in a rat model of preeclampsia. Pathophysiology 25, 389\u2013395 (2018).","journal-title":"Pathophysiology"},{"key":"417_CR339","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11010-019-03599-4","volume":"461","author":"V Kasture","year":"2019","unstructured":"Kasture, V. et al. Maternal omega-3 fatty acids and vitamin E improve placental angiogenesis in late-onset but not early-onset preeclampsia. Mol. Cell Biochem. 461, 159\u2013170 (2019).","journal-title":"Mol. Cell Biochem."},{"key":"417_CR340","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1161\/HYPERTENSIONAHA.117.08821","volume":"70","author":"S Goulopoulou","year":"2017","unstructured":"Goulopoulou, S. Maternal vascular physiology in preeclampsia. Hypertension 70, 1066\u20131073 (2017).","journal-title":"Hypertension"},{"key":"417_CR341","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2174\/1389201021666191217114111","volume":"21","author":"X Feng","year":"2020","unstructured":"Feng, X. et al. Comparison of vascular responses to vasoconstrictors in human placenta in preeclampsia between preterm and later term. Curr. Pharm. Biotechnol. 21, 727\u2013733 (2020).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"417_CR342","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.placenta.2020.09.001","volume":"101","author":"A Langston-Cox","year":"2020","unstructured":"Langston-Cox, A., Leo, C. H., Tare, M., Wallace, E. M. & Marshall, S. A. Sulforaphane improves vascular reactivity in mouse and human arteries after \u201cpreeclamptic-like\u201d injury. Placenta 101, 242\u2013250 (2020).","journal-title":"Placenta"},{"key":"417_CR343","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000410668","volume":"13","author":"H Schneider","year":"1985","unstructured":"Schneider, H. & Huch, A. Dual in vitro perfusion of an isolated lobe of human placenta: method and instrumentation. Contrib. Gynecol. Obstet. 13, 40\u201347 (1985).","journal-title":"Contrib. Gynecol. Obstet."},{"key":"417_CR344","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/labinvest.2014.76","volume":"94","author":"A Jain","year":"2014","unstructured":"Jain, A. et al. Hypoxic treatment of human dual placental perfusion induces a preeclampsia-like inflammatory response. Lab. Invest. 94, 873\u2013880 (2014).","journal-title":"Lab. Invest."},{"key":"417_CR345","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.placenta.2011.01.017","volume":"32","author":"K May","year":"2011","unstructured":"May, K. et al. Perfusion of human placenta with hemoglobin introduces preeclampsia-like injuries that are prevented by \u03b11-microglobulin. Placenta 32, 323\u2013332 (2011).","journal-title":"Placenta"},{"key":"417_CR346","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.placenta.2010.10.011","volume":"32","author":"S Guller","year":"2011","unstructured":"Guller, S. et al. Protein composition of microparticles shed from human placenta during placental perfusion: potential role in angiogenesis and fibrinolysis in preeclampsia. Placenta 32, 63\u201369 (2011).","journal-title":"Placenta"},{"key":"417_CR347","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.placenta.2006.05.005","volume":"28","author":"S Guller","year":"2007","unstructured":"Guller, S., Ma, Y., Malek, A., Di Santo, S. & Schneider, H. Differential release of plasminogen activator inhibitors (PAIs) during dual perfusion of human placenta: implications in preeclampsia. Placenta 28, 278\u2013285 (2007).","journal-title":"Placenta"},{"key":"417_CR348","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41586-018-0753-3","volume":"564","author":"MY Turco","year":"2018","unstructured":"Turco, M. Y. et al. Trophoblast organoids as a model for maternal-fetal interactions during human placentation. Nature 564, 263\u2013267 (2018).","journal-title":"Nature"},{"key":"417_CR349","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41572-020-00228-z","volume":"6","author":"E Dimitriadis","year":"2020","unstructured":"Dimitriadis, E., Menkhorst, E., Saito, S., Kutteh, W. H. & Brosens, J. J. Recurrent pregnancy loss. Nat. Rev. Dis. Primers 6, 98 (2020).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"417_CR350","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.cnc.2022.04.009","volume":"34","author":"M Adorno","year":"2022","unstructured":"Adorno, M., Maher-Griffiths, C. & Grush Abadie, H. R. HELLP syndrome. Crit. Care Nurs. Clin. North Am. 34, 277\u2013288 (2022).","journal-title":"Crit. Care Nurs. Clin. North Am."}],"updated-by":[{"DOI":"10.1038\/s41572-023-00451-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000}}],"container-title":["Nature Reviews Disease Primers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41572-023-00417-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-023-00417-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-023-00417-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T18:08:42Z","timestamp":1733940522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41572-023-00417-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":350,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["417"],"URL":"https:\/\/doi.org\/10.1038\/s41572-023-00417-6","relation":{},"ISSN":["2056-676X"],"issn-type":[{"value":"2056-676X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]},"assertion":[{"value":"4 January 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2023","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41572-023-00451-4","URL":"https:\/\/doi.org\/10.1038\/s41572-023-00451-4","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.d.S.C. has Research Funding from ThermoFisher for an angiogenic marker study (sFLT1\/PGF). The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}